Trading Analysis Report: CARR¶

Analysis date: 2026-10-21
Rating: Underweight
Generated: 2026-10-21 12:04:38
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 56.27 Price As Of: 2026-10-21

CARR (Carrier Global Corporation, NYQ): Technical Report as of 2026-10-21¶

1. Summary¶

CARR is in a broad downtrend on every SuperTrend timeframe, but it has been making a short-term recovery since mid-September. The long-term structure is bearish: price is below both the 50 SMA and the 200 SMA, and the 50 SMA has been below the 200 SMA since 2026-09-24. Near-term momentum has improved, with a positive MACD histogram, RSI back to about 52, and price above the 10 EMA. The bounce has not yet reclaimed any major trend level. The evidence reads as a counter-trend rebound inside a larger downtrend, not a confirmed reversal.

Data caveat: The 2026-10-21 bar looks like a partial session. Its volume is about 1.74M, against roughly 4.9M average for completed October sessions (my arithmetic from the CSV). The close of 56.27 may still change.

Source discrepancy: The price CSV shows 10-21 volume of 1,736,901. The verified snapshot shows 1,737,190. The OBV tool output matches the snapshot figure. I used the snapshot as the source of truth. The gap is tiny and doesn't affect any conclusion.

2. Price Context¶

Item	Value	Source/Date
Latest close	56.27	Snapshot, 2026-10-21
Latest session range	55.83–56.62 (open 56.51)	Snapshot
Peak close in the window	75.73	2026-06-25
Lowest close in the window	49.79	2025-11-20
Recent swing-low close	53.88	2026-09-18
Recent swing-low intraday	52.96	2026-09-18

Rally: From 49.79 (2025-11-20) to 75.73 (2026-06-25), a gain of about 52%.
Decline: From 75.73 to 53.88 (2026-09-18), a drop of about 29%. The price is now about 25.7% below the June peak.
Gap-downs on heavy volume:
On 2026-07-28 the close fell from 69.33 to 63.16 on about 16.4M shares.
On 2026-07-29 the close fell to 59.92 on about 16.6M shares.
The tools don't say what caused these moves.
September capitulation:
The close slid from 57.26 (09-14) to 53.88 (09-18).
09-15 volume was about 13.3M.
09-18 volume was about 21.4M, the second-highest in the window.
The tools don't explain the cause. The third-Friday timing would fit options expiry or index rebalancing, but that is unverified.
Current range: Closes since 09-16 have stayed between 53.88 and 56.37. The 10-21 close of 56.27 sits near the top of that range. The 10-21 high of 56.62 is still below the 09-25 high of 56.79.
Recent bounce: The close rose from 54.24 (10-14) to 56.27, about 3.7%. The 10-20 gain of about 1.7% came on roughly 4.9M shares, which is average volume, not a surge.

3. Trend Indicators¶

Moving averages

MA	Value	Notes
10 EMA	55.50	Price is above it, which is short-term constructive.
50 SMA	57.23	Falling steadily: 61.82 (09-21), 59.49 (10-02), 57.23 (10-21). Price is about 1.7% below it.
200 SMA	61.51	Nearly flat, drifting up from 61.23 (09-21). Price is about 8.5% below it.

Death cross: The 50 SMA was above the 200 SMA on 09-23 (61.272 vs 61.244). It was below on 09-24 (60.9995 vs 61.2503). This is a lagging, bearish structural signal.
50 SMA slope: It is still sloping down. The days dropping out of its window (mid-August closes of about 61–63) are higher than current prices. Even with flat price, it should keep drifting toward the current price. A reclaim of the 50 SMA could therefore get easier without much price progress. That is a mechanical observation, not a forecast.
10 EMA: It is the nearest dynamic support at 55.50. It is only about 1.4% below the close.

SuperTrend (14-period, 3x ATR). Weekly outranks monthly, which outranks daily.

Tier	Direction	Stop level	Close vs stop
Weekly (primary)	DOWN	66.98	-16.00%
Monthly (regime)	DOWN	75.97	-25.93%
Daily (entry timing)	DOWN	58.47	-3.76%

All three tiers agree, so the higher-tier trend is bearish.
The daily stop at 58.47 is the nearest flip level. A daily close above it would flip the daily trend. That would be the first timeframe-level evidence of a turn, though the weekly and monthly trends would remain down.
The weekly stop (66.98) and monthly stop (75.97) are far away. They indicate the downtrend is not close to being structurally reversed.

4. Momentum Indicators¶

MACD (snapshot values)

MACD line: -0.44
Signal line: -0.73
Histogram: +0.28

The MACD line is above its signal line, so the histogram is positive. The line has risen steadily from -2.08 (09-21) to -0.44. The MACD line is still below zero, so this is a bullish crossover below the zero line. In a downtrend that is generally a lower-quality signal than one above zero. It shows downside momentum fading, not an established uptrend.

RSI (14)

Latest reading: 52.01.
Path: 31.97 (09-21), 34.55 (09-24), 37.57 (09-30), 37.69 (10-14), 44.78 (10-19), 51.37 (10-20), 52.01 (10-21).
The reading was close to oversold on 09-21, though it stayed above 30 in this window. It has now recovered to neutral.
RSI is neither overbought nor oversold, so it gives no stretch signal. It does confirm that bearish momentum has eased.

5. Volatility¶

ATR: 1.38, about 2.5% of price. It has contracted from 1.84 on 09-21, as the September selloff has calmed.
Bollinger Bands (snapshot):
Middle band 55.41.
Upper band 56.54.
Lower band 54.28.
The close of 56.27 is within about 0.27 of the upper band. The bands are fairly narrow, with width about 4.1% of the middle band.
Reading: Price is at the upper edge of a recent compression range. A close above the upper band would be an upside volatility expansion from the current range. Failure here would keep price inside the range. Bands tell you where the stretch is, not which way it breaks.
Illustrative ATR distances: One ATR is about 1.38 and two ATRs are about 2.76. Two ATRs below the close is about 53.51. That is just under the 09-18 swing-low close of 53.88 and above the 09-18 intraday low of 52.96. This is a sizing reference, not a recommendation.

6. Volume (OBV)¶

OBV is deeply negative at about -78.9M, and its absolute level carries no meaning.
Within the window, OBV rose from a low of -102.5M (10-14) to -78.9M, a gain of about 23.7M over five sessions. That fits the price bounce, so the rebound has some volume support.
OBV is not trending up over the whole 30-day window. It was -84.0M on 09-21 and is -78.9M now, so it is range-bound.
OBV on 10-14 (-102.5M) was lower than 09-21 (-84.0M). It was also lower than the 09-18 level I derived from the 09-21 reading and volume (about -90.8M). Price on 10-14 closed at 54.24, above the 09-18 close of 53.88. That suggests some distribution during the early-October pullback despite higher price lows. This is a tentative inference, and the recovery since then partly offsets it.
Today's OBV change includes a partial-day volume, so it may shift.

7. Stretch and Exhaustion (Z-Score)¶

Timeframe	Z-score	Reading
Weekly (primary)	-0.95	Near the mean, mildly below
Monthly (regime)	-0.92	Near the mean, mildly below
Daily (timing)	+1.53	Moderately above the mean, below the

The weekly and monthly readings are in line with each other and outweigh the daily one. There is no statistically stretched condition on any timeframe. The daily reading is consistent with price sitting near the upper Bollinger Band. I did not run TD-9, so I have no exhaustion-count data.

8. Key Levels (all from tool output)¶

Level	Price	Basis
Upper Bollinger Band	56.54	Snapshot
Recent intraday highs	56.62 (10-21), 56.79 (09-25)	CSV
50 SMA	57.23	Falling; the first major trend hurdle
09-11 close	57.46	CSV
Daily SuperTrend stop	58.47	Daily trend flip level
200 SMA	61.51	Long-term benchmark
Weekly SuperTrend stop	66.98	Primary-trend flip level
10 EMA	55.50	Nearest dynamic support
Bollinger middle	55.41	Snapshot
Lower Bollinger Band	54.28	Snapshot
09-18 close / intraday low	53.88 / 52.96	CSV; swing low

9. Scenarios¶

Bullish continuation (needs confirmation) - A daily close above the 56.5–56.8 area would clear the recent range top and the upper band. - Reclaiming the 50 SMA (57.23) and then flipping the daily SuperTrend (a close above 58.47) would be the first structural evidence of a turn. - Confirmation would be stronger if OBV makes new highs for the window and MACD moves above zero. - Even then, the weekly and monthly SuperTrend stay bearish. The 200 SMA (61.51) is a major overhead reference.

Bearish resumption - Rejection at the 56.5–57.5 zone, then a loss of the 10 EMA (55.50) and Bollinger middle (55.41), would indicate the bounce has failed. - The next references would be the lower band (54.28), then the 09-18 swing low (close 53.88, intraday 52.96). - Because the 50 SMA is below the 200 SMA and all SuperTrend tiers are down, the higher-timeframe bias favors this path unless the bounce is confirmed.

Sideways (also plausible) - ATR is contracting, RSI is neutral, and price has held a roughly 53.9–56.4 close range for five weeks. Continued range trading is a real possibility, and the Bollinger Band width supports it.

10. Observations for the Decision-Maker¶

Higher-timeframe evidence is bearish. SuperTrend is down on all three tiers, price is below the 50 and 200 SMAs, and the death cross has occurred.
Lower-timeframe evidence is improving. MACD is turning up, RSI has normalized, price is above the 10 EMA, and OBV is rebounding. This is consistent with a rebound, not a confirmed trend change.
Price is at a decision point. It is at the top of its range and the upper Bollinger Band, below the 50 SMA, and 3.8% below the daily SuperTrend stop.
Tools give no valuation, earnings, or catalyst information. This report is technical only. Fundamentals, upcoming events, and sector context need separate analysis.

Summary Table¶

Category	Indicator	Latest value	Interpretation
Price	Close (2026-10-21)	56.27	Possible partial session; volume about 1.74M
Trend	10 EMA	55.50	Price above; short-term support
Trend	50 SMA	57.23	Price below; falling
Trend	200 SMA	61.51	Price about 8.5% below; flat
Trend	50/200 cross	Death cross on 2026-09-24	Bearish structure
Trend	SuperTrend weekly	DOWN, stop 66.98 (-16.00%)	Primary trend bearish
Trend	SuperTrend monthly	DOWN, stop 75.97 (-25.93%)	Regime bearish
Trend	SuperTrend daily	DOWN, stop 58.47 (-3.76%)	Nearest flip level
Momentum	MACD / signal / histogram	-0.44 / -0.73 / +0.28	Bullish crossover below zero; fading downside momentum
Momentum	RSI (14)	52.01	Neutral; up from 31.97 on 09-21
Volatility	ATR (14)	1.38 (about 2.5% of price)	Contracting from 1.84
Volatility	Bollinger lower / middle / upper	54.28 / 55.41 / 56.54	Price near upper band
Volume	OBV	-78.9M	Rebounding from -102.5M (10-14); range-bound over the window
Stretch	Z-score weekly / monthly / daily	-0.95 / -0.92 / +1.53	No stretch signal; daily mildly elevated
Key resistance	56.54–56.79, 57.23, 58.47, 61.51	Upper band/recent highs, 50 SMA, daily SuperTrend stop, 200 SMA	Layered overhead supply zones
Key support	55.50, 55.41, 54.28, 53.88 (52.96 intraday)	10 EMA, Bollinger middle, lower band, swing low	Layered support zones
Data flag	10-21 volume	CSV 1,736,901 vs snapshot 1,737,190	Minor mismatch; snapshot used

I didn't run TD-9, the KDJ lines, ADX/DI, or MFI.

Sentiment Analyst¶

Overall Sentiment: Mildly Bearish (Score: 3.8/10) Confidence: Low

Scope and data quality (CARR, Carrier Global Corporation, NYSE, window 2026-10-14 to 2026-10-21). Only two of the three sources returned data. Reddit was disabled by config, so r/wallstreetbets, r/stocks and r/investing are silent. StockTwits returned just 3 messages, all unlabeled (0 Bullish / 0 Bearish), so there is no usable bull/bear ratio. The news feed is partly noisy. Three headlines (Morgan Stanley downgrading Carrefour, 3i Group falling on the Carrefour read-across, Carrefour shares down 11% on a guidance cut) concern the French retailer Carrefour and its read-across, not Carrier Global. They appear to be ticker-similarity false matches and are excluded from the sentiment read. Treat all conclusions below as low-confidence.

1. Source-by-source breakdown

News (Yahoo Finance, about 7 days). Roughly 7 of 13 headlines are about CARR, and they lean negative, driven by analyst actions: - Goldman Sachs downgraded CARR to Neutral from Buy with a $61 price target. This is the anchor event. The StockTwits timestamps place it on 2026-10-14, and MT Newswires reported that CARR shares fell on the downgrade. - Stephens cut its target to $55 from $65 (about -15%), the lowest target in the set. - RBC cut its target to $72 from $82 (about -12%) but kept Outperform. - Mizuho trimmed its target to $70 from $75 (about -7%). The rating change, if any, is not stated. - Insider Monkey's 'Mixed Results Pressured Carrier Global Corporation (CARR)' frames recent performance as mixed and a drag on the stock. The headline gives no specifics. - Simply Wall St asks 'Does CARR Look Cheap After Its $433M Plant Plan?' This is a valuation and capex framing that is neutral to slightly constructive. Plant location, purpose and returns are not in the data provided. - StockStory's 'Spotting Winners: Carrier Global and HVAC and Water Systems Stocks in Q2' is a sector roundup with no clear direction from the headline alone. It also appears to be retrospective, covering Q2. - The two Comfort Systems pieces (a Q3 earnings preview and a cash-flow article) are peer and sector context only. They suggest Q3 earnings season is underway for HVAC-adjacent names. CARR's own earnings date is not in the data.

All four price-target actions are cuts, and the one rating change is a downgrade. No upgrades or target raises for CARR appear in the window. The $55-$72 target range is wide, but the current share price is not provided, so implied upside or downside cannot be computed.

StockTwits (3 messages, all unlabeled). - @briefingcom (2026-10-14 12:40Z) relays the Goldman downgrade to Neutral with a $61 target. This is a factual relay, not opinion. - @ItsCarRamRod (2026-10-14 16:43Z) reads gleeful about the downgrades. The post argues that 'no average person can afford these overpriced' A/C systems, which is a consumer-affordability and demand-weakness thesis. The tone is bearish toward CARR, but the post carries no sentiment label and is a single anecdotal voice. - @KryptonResearch14 (2026-10-14 18:35Z) is tagged $TT (Trane), not CARR. It says Goldman upgraded Trane to Buy from Neutral with a $565 target. Goldman's FY2027 Trane estimates are about 4% above consensus, and backlogs at Trane and Johnson Controls are up roughly 50% on average this year on large-scale cooling demand. The linked Seeking Alpha headline says Trane was upgraded while Lennox and Carrier were downgraded. This implies a relative-preference call away from CARR toward peers with data-center and large-scale cooling exposure.

Reddit. Disabled. No evidence either way, and no inference should be drawn from its absence.

2. Cross-source divergences and alignments There is no meaningful divergence. News and the little StockTwits content point the same way, and all of it traces back to the same Goldman event. Retail chatter is an echo of institutional news rather than an independent signal. There are no labeled bullish posts to offset it, and the sample is too small to say whether retail is leaning bullish or bearish. One partial offset is RBC's Outperform, kept even with the lower target, which shows the sell-side is not uniformly negative. Valuation-oriented coverage (Simply Wall St) also asks whether the stock has become cheap, which hints at a possible dip-buyer narrative. That is a question in a headline, not evidence of buying.

3. Dominant narrative themes - Sell-side target compression and downgrade momentum: four target or rating cuts clustered in the window. - Relative positioning within HVAC: capital is being steered toward data-center and large-scale cooling beneficiaries (Trane, Johnson Controls) and away from residential and light-commercial exposure (Carrier, Lennox). - Residential demand and affordability: the retail post and the 'mixed results' headline both fit a softer end-demand narrative, though the evidence is thin. - Capex and valuation: the $433M plant plan raises the question of whether the shares are now cheap or whether investment adds execution risk.

4. Catalysts and risks surfaced by the data - Upcoming CARR Q3 results and guidance are the likely next catalyst, since peers are in earnings-preview mode. The exact date is not in the data. Lowered targets may mean estimates are being reset ahead of the print, which could lower the bar or signal a guidance cut. - Risk: further estimate cuts or downgrades if residential or light-commercial volumes stay weak. - Risk: continued rotation toward data-center cooling peers with 50%-type backlog growth. - Possible upside: RBC's Outperform, a valuation reset after the target cuts, and a new plant that may add capacity or margin. None of these is substantiated beyond the headlines. - Data caveat: the downgrade-driven price reaction magnitude, current price and volume are not provided.

5. Summary table

Signal	Direction	Source	Evidence
Goldman downgrade to Neutral, PT $61	Bearish	News / StockTwits	MT Newswires headline plus @briefingcom relay on 2026-10-14; shares reported lower
Stephens PT cut to $55 from $65	Bearish	News	MT Newswires; largest cut (~15%) and lowest target
RBC PT cut to $72 from $82, keeps Outperform	Mildly Bearish	News	MT Newswires; target down ~12% but rating retained
Mizuho PT to $70 from $75	Mildly Bearish	News	MT Newswires; ~7% trim, rating change not stated
'Mixed results pressured CARR'	Mildly Bearish	News (Insider Monkey)	Headline only; no specifics
$433M plant plan / 'look cheap?'	Neutral to Mildly Bullish	News (Simply Wall St)	Valuation and capex framing; no details
Rotation to Trane, away from Lennox and Carrier	Bearish (relative)	StockTwits ($TT post)	Goldman upgraded Trane; backlogs at Trane and JCI up ~50% on large-scale cooling
Retail affordability complaint	Mildly Bearish	StockTwits (@ItsCarRamRod)	Single unlabeled, anecdotal post
Carrefour / 3i Group headlines	Excluded	News	Different company (ticker-similarity noise)
Reddit	No data	Reddit	Disabled by config
StockTwits bull/bear ratio	Not measurable	StockTwits	0 Bullish / 0 Bearish / 3 unlabeled

Bottom line: Sentiment on CARR is mildly bearish. The read rests almost entirely on a cluster of analyst downgrades and target cuts around 2026-10-14, plus a thin retail echo. It is not a robust crowd-sourced signal, because the sample is tiny, unlabeled and Reddit is missing. It is an input for the trader to weigh against fundamentals, valuation and the upcoming earnings report, not a price call.

News Analyst¶

CARR (Carrier Global Corporation, NYSE) – Weekly News and Macro Report, 14–21 Oct 2026¶

1. Data limitations¶

FRED macro data failed. Every get_macro_indicators call returned DATA_UNAVAILABLE. That covers fed funds, 10-year Treasury, yield curve, CPI, core PCE, unemployment, VIX and real GDP, including retries with raw series IDs. I have no actual readings for rates, inflation, labor or volatility, and I haven't estimated any. The macro section relies on prediction markets and headlines only.
Company news is headline-only. I got titles and sources, not article text. Details such as the "$433M plant plan" and the earnings date are unconfirmed.
Some "CARR" results are the wrong company. Three items are about Carrefour (the French retailer), not Carrier: the Morgan Stanley downgrade, the 3i Group read-across and the 11% share drop. Ignore them for CARR. Carrefour's profit warning is a France retail story.
I have no price data. I can't say where CARR trades relative to the price targets below.

2. CARR company news¶

Sell-side sentiment has turned negative. Five target changes appeared in the Oct 1–21 window. The headlines don't give exact dates.

Firm	Action	New target	Prior target	Change
Goldman Sachs	Downgrade to Neutral	$61	n/a	Shares fell on the news
RBC	Cut, keeps Outperform	$72	$82	−12.2%
Mizuho	Cut	$70	$75	−6.7%
Bernstein	Cut	$64	$78	−17.9%
Stephens	Cut	$55	$65	−15.4%

The five targets average about $64.4 and range from $55 to $72.
The cuts are broad, from 6.7% to 17.9%. That pattern points to a sector or fundamental reset ahead of Q3 earnings, not one analyst's view.
RBC and Mizuho still carry higher targets. The Goldman downgrade is the main sentiment event.
Bernstein and Stephens sit at the low end. Those lower marks may reflect expectations for the Q3 print or the guidance.

Other CARR items (headlines only): - Q3 2026 earnings advisory (PR Newswire) and a Barchart "What to Expect" preview. Earnings are imminent. The exact date wasn't in the retrieved text, so confirm it on the press release. Expect elevated implied volatility and a larger-than-normal move after the cuts. - Quarterly dividend declared. The amount wasn't retrieved. - "Does CARR Look Cheap After Its $433M Plant Plan?" (Simply Wall St.). This indicates a sizable capital-investment announcement. I couldn't retrieve what it covers or where the plant is. - "Mixed Results Pressured Carrier Global" (Insider Monkey). This reads as a fund-letter comment that results were mixed. I couldn't confirm the content. - Comfort Systems (FIX) Q3 preview and cash-flow pieces (Zacks). Comfort Systems is a mechanical/HVAC contractor, so its print is a possible read-through for HVAC and commercial construction demand. I don't know its date or results.

3. Macro backdrop from prediction markets¶

These are crowd-implied odds, and several markets are thin. Volumes are in brackets.

Fed, October meeting (resolves Oct 29, deep volume of $7–15M per contract): - No change: 86%, up 18pp on the week. - 25bp hike: 12%, down 18pp on the week. - Any cut: about 0%. - Hike odds fell sharply in one week, so the market moved toward a hold.

Fed path for the rest of 2026 (thinner markets, $0.07–0.9M): - "Another Fed rate hike in 2026?" 80% (−5pp). It resolves Dec 10, so it points to the December meeting. - "Will 2 hikes happen in 2026?" is at 70%, "1 hike" at 20%, and "3 hikes" at 9%. - "No Fed cuts in 2026" is at 97% ($9M volume). - Taken together, the market sees no easing this year, a likely hold in October, and a meaningful chance of a further hike by December. I couldn't verify the current policy rate because the FRED call failed. The hike-count contracts appear to count the whole of 2026, so I wouldn't read them as additional hikes from here. - The October "no one dissents" market is at 24% (−11pp), but it has only $14k of volume. It hints at committee disagreement and is low reliability.

Growth: - US recession by end of 2026: 8% ($2.3M volume). That's low. - UK recession: 6%. Japan recession: 4%. Both are very thin markets.

Trade and tariffs (thin, $3k–$93k): - A US–Canada tariff-reduction deal by Oct 31 is at 5%, and by Dec 31 at 40%. - Section 232 tariffs on copper cable by end-2026 are at 28% (−16.5pp) and by end-2027 at 48%. - Copper is relevant to HVAC input costs, but the volumes are too small to lean on.

Government shutdown market: it bundles House-control outcomes and carries little signal. I'd skip it.

4. Global market news¶

Headlines are dominated by mega-cap tech and AI earnings season: Meta, Tesla, IBM and SAP, plus a "SpaceX blowout quarter" that lifted Nasdaq/S&P futures and chip stocks.
Pre-bell moves were up, and the tape looks risk-on and tech-led.
Gold and silver were firm, and oil slipped (WSJ). That's mildly disinflationary for input and freight costs, but I have no price levels.
No retrieved headlines on inflation, jobs or GDP.
There was a related item on AI infrastructure power demand ("Price of the Watt"). It's an indirect link to data-center cooling demand, a theme HVAC names trade on, but it isn't specific to CARR.

5. Implications for CARR¶

These are interpretations, not data. The sector points are general knowledge, not from the tools.

Event risk is concentrated in the next 1–2 weeks. CARR's Q3 print and the Oct 28–29 FOMC meeting land close together. With estimates and targets cut, the bar looks lower, which can help a beat. Guidance, especially for residential HVAC and the commercial/data-center mix, is the swing factor.
Rates are a headwind with no relief priced. The market sees no cuts in 2026 and some chance of another hike. That is unfavorable for rate-sensitive end markets like residential housing and construction, and it weighs on valuation multiples.
Growth fear is low. An 8% recession probability, a risk-on tape and a tech-capex boom favor data-center and commercial cooling demand. Rate sensitivity is the offset.
Rotation risk. Capital is flowing to AI and tech names. Industrials like CARR may lag unless the print or guidance revives the data-center narrative.
Sentiment is a two-way risk. After the downgrade and target cuts, the setup could squeeze higher on a clean print. Alternatively, a guidance cut could bring a further wave of downgrades.

6. What to watch¶

The CARR Q3 earnings date and the Q4/FY guidance.
The Comfort Systems Q3 print as a read-through.
The Oct 28–29 FOMC decision, the dissent count, and any December hike signaling.
Whether the $433M plant plan is linked to capacity expansion or tariff mitigation.
Any Section 232 copper or metals tariff decision.
Re-pull the FRED data (yields, CPI, VIX) once the tool recovers, to confirm the rate-path narrative.

7. Summary table¶

Category	Key point	Source / reliability	Takeaway for CARR
Data gaps	All FRED macro calls failed; no price data	Tool error	Rates, inflation, labor and VIX are unverified
Data quality	Carrefour headlines in the CARR feed	News feed	Ignore; a different company
Analyst actions	Goldman cut to Neutral ($61); RBC $72 (from $82); Mizuho $70 (from $75); Bernstein $64 (from $78); Stephens $55 (from $65)	Headlines, MT Newswires	Broad negative revision; average target about $64.4
Earnings	Q3 2026 advisory and Barchart preview out; date not retrieved	Headlines	Imminent catalyst; confirm date
Capex	$433M plant plan	Simply Wall St. headline	Growth or tariff-mitigation signal; details unknown
Dividend	Quarterly dividend declared	PR Newswire headline	Amount not retrieved
Peer read-through	Comfort Systems Q3 preview	Zacks headlines	Possible HVAC/commercial demand signal
Fed, October	Hold 86%, hike 12%, cut about 0%	Polymarket, deep volume	Hold likely; hike risk fell 18pp in a week
Fed, 2026 path	No cuts 97%; another hike by December 80%	Polymarket, thinner volume	No easing priced; rate-sensitive end markets stay pressured
Recession	US recession by end-2026 at 8%	Polymarket, $2.3M	Low growth fear
Tariffs	Copper cable Section 232 at 28% by end-2026; US–Canada deal 5% by Oct 31	Polymarket, very thin	Input-cost risk; low confidence
Global tape	Tech/AI earnings-led, risk-on; gold and silver firm, oil softer	Headlines	Industrials may lag; the data-center link is indirect
Key dates	CARR Q3 earnings (date TBC); FOMC Oct 28–29	Headlines / Polymarket	Event risk clustered in the next 1–2 weeks

Fundamentals Analyst¶

CARR (Carrier Global Corporation) Fundamental Report¶

Industrials / Building Products & Equipment, NYSE. Analysis date: 2026-10-21.

0. Data caveats¶

The financial statements are stale. The latest filed period in the income statement, balance sheet and cash flow is Q1 2026 (3/31/2026). Q2 2026 (June) is missing even though it should have been filed by now. Q3 2026 results are not out yet. Carrier has historically reported Q3 in late October, so an earnings event is likely imminent. I haven't confirmed the date.
No week-specific data. None of these tools returns news or filings from the past week. Everything below is the most recent data available.
Some quarters are missing. The income statement has no Q4 columns, and Q3 2021 is also absent.
Cash flow is year-to-date. The cash flow figures are cumulative (3-, 6- and 9-month), not discrete quarters.
Cost of revenue and gross profit are not tagged in the quarterly filings. The only gross profit figure comes from the fundamentals snapshot.
Company background context is labeled "(context)". It comes from my general knowledge, not from the tools.

1. Snapshot and valuation¶

Metric	Value
Market cap	~$46.4B
Implied share price	~$56.3 (from P/B 3.53 × book value $15.935, and TTM P/E × EPS)
52-week range	$50.24 – $76.76
50-day / 200-day average	$57.37 / $61.75
Beta	1.29
P/E (TTM)	40.8x
Forward P/E	17.0x
PEG	1.07
Price/book	3.53x
EPS (TTM, GAAP)	$1.38
Forward EPS	$3.31
Dividend yield	1.71%

Observations - Price vs. trend: The stock sits about 27% below its 52-week high and about 12% above its low. It is below both its 50-day and 200-day averages, which is a downtrend. The 50-day average is also below the 200-day average, a bearish "death cross" configuration. - TTM vs. forward earnings: TTM P/E of 40.8x against forward P/E of 17.0x is a large gap. It implies the market expects EPS to rise from $1.38 to about $3.31, a 2.4x increase. The forward figure is probably adjusted (ex-items) while TTM is GAAP, so the two are not like-for-like. The recent GAAP quarters are not supporting that recovery yet (see Section 2). - Free cash flow yield: TTM FCF of ~$862M is about 1.9% of market cap. That is thin for a 17x forward P/E stock.

2. Income statement trends (USD millions)¶

Quarter	Revenue	YoY	Operating income	Op. margin	Net income	Diluted EPS
Q1 2024	5,420		385	7.1%	269	0.29
Q2 2024	5,934		724	12.2%	2,337*	2.55*
Q3 2024	5,984		763	12.8%	447	0.49
Q4 2024	5,148		774	15.0%	n/a	n/a
Q1 2025	5,218	−3.7%	629	12.1%	412	0.47
Q2 2025	6,113	+3.0%	903	14.8%	591	0.68
Q3 2025	5,579	−6.8%	539	9.7%	428	0.50
Q1 2026	5,341	+2.4%	259	4.8%	238	0.28

*Q2 2024 net income was inflated by a large one-time gain, which I infer from the size of the figure. It is not a run-rate number.

Key takeaways 1. Revenue is flat to slightly growing, but profitability is falling sharply. Q1 2026 revenue rose 2.4% YoY, but operating income fell about 59% (629 → 259), net income fell about 42% (412 → 238), and EPS fell about 40% (0.47 → 0.28). 2. Q1 2026 operating income is the lowest in the whole series shown (since 2019). It is below even the Q1 2020 COVID quarter (315). The tools don't say why. Possible causes are restructuring, impairments, a weak mix or volume, or cost inflation. This needs checking in the 10-Q or the earnings release. 3. Q3 2025 was already weak. Revenue fell 6.8% YoY and operating income fell about 29% (763 → 539), so margins were deteriorating before Q1 2026. 4. TTM figures (from the fundamentals snapshot): - Revenue: $22.1B. - Gross profit: $5.46B (24.7% margin). - EBITDA: $3.09B. - Net income: $1.17B (5.5% margin). - Operating margin: 13.1%. This is much higher than the latest quarter's 4.8%, so it may reflect a different period or definition. Treat it with caution. 5. Implied Q4 2025 weakness: The quarterly EPS for Q2 2025, Q3 2025 and Q1 2026 sums to about $1.46. TTM EPS is $1.38. If the TTM window ends at Q1 2026, Q4 2025 EPS would be about −$0.08, a roughly breakeven or negative quarter. This is an inference with low confidence because the Q4 data is missing. 6. Returns are modest: ROE is 9.0% and ROA is 3.0%.

3. Balance sheet (USD millions)¶

Date	Total assets	Cash	Current assets	Current liabilities	Total liabilities	Equity
2024-03-31	40,810	1,180	11,715	8,637	28,904	11,906
2024-12-31	37,403	3,969	9,891	7,892	23,008	14,395
2025-09-30	38,077	1,423	8,839	7,747	23,238	14,839
2025-12-31	37,190	1,555	8,533	7,114	23,062	14,128
2026-03-31	37,186	1,371	9,018	8,585	23,385	13,801

Key takeaways - Large post-acquisition balance sheet: Total assets jumped from about $26.5B in 2023 to about $40.8B in Q1 2024. This matches the large Q1 2024 investing outflow of about $11.1B, which is consistent with the Viessmann Climate Solutions acquisition (context). The deleveraging that followed took liabilities from $28.9B to about $23B. - Cash has fallen: It dropped from $3.97B at the end of 2024 to $1.37B in Q1 2026. This follows heavy financing outflows (Section 4). - Liquidity is thin: - The current ratio is about 1.02 per the snapshot, or about 1.05 from the Q1 2026 balance sheet (9,018 / 8,585). - Current liabilities rose by about $1.5B in one quarter (7,114 → 8,585). That may be seasonal working capital or a reclassification of debt to short-term. It is worth checking the debt maturity schedule. - Leverage: - Debt-to-equity is 0.92x. That implies total debt of about $12–13B (a derived estimate; the debt line is not in the tool output). - Against $3.09B of EBITDA, net leverage works out to roughly 3.5–4x on that EBITDA. This is higher than company-adjusted figures would show, because adjusted EBITDA is larger. - Equity is shrinking: It fell from $15.0B (Q3 2024) to $13.8B, consistent with buybacks and dividends exceeding retained earnings. - Book value: $15.94 per share. The stock trades at 3.5x book.

4. Cash flow (USD millions, year-to-date cumulative)¶

Period	Operating CF	Capex	FCF (OCF − capex)	Investing CF	Financing CF
Q1 2025	483	63	420	−23	−2,747
6M 2025	1,132	144	988	−78	−3,294
9M 2025	1,473	261	1,212	−197	−3,885
9M 2024	431	302	129	−5,114	−2,950
Q1 2026	79	94	−15	−65	−141

Key takeaways - Q1 2026 free cash flow was slightly negative (about −$15M), against +$420M in Q1 2025. Q1 is seasonally the weakest cash quarter, but this is a big YoY decline and matches the earnings weakness. Capex rose about 49% YoY (63 → 94). - The 2025 financing outflows were large: −$3.9B over nine months, and cash fell by about $2.5B. The tools don't split this into buybacks, dividends and debt repayment. Equity falling and liabilities staying flat suggest a lot of it was shareholder returns. - Q1 2026 financing outflows were only −$141M. That is a sharp slowdown in capital returns and deleveraging from the 2025 pace, which is consistent with cash and FCF being tight. - TTM FCF is ~$862M, and the dividend uses most of it. - The implied dividend is about $0.96 per share (1.71% × $56.3, derived), or roughly $0.8B a year. - That is about 90% of TTM FCF and about 70% of TTM GAAP EPS. - Coverage is thin unless FCF recovers. - Normal seasonality: The first half of the year consumes cash and the second half generates it. The 9M 2025 FCF of $1.2B shows that pattern, so Q2 and Q3 2026 cash flow will be important to check.

5. Insider activity¶

Date	Insider	Role	Action	Shares	Price	Value
2026-05-20	Maximilian Viessmann	Director (indirect)	Sale	12,094,823	$62.01	~$750M
2025-11-25	David Gitlin	CEO	Open-market purchase	19,300	$52.62	~$1.02M
2025-06-05	Maximilian Viessmann	Director (indirect)	Sale	4,267,425	$70.30	~$300M
2025-02-14	Kyle Crockett	Officer	Option exercise + sale	18,945 sold	$65.18	~$1.23M
2024-11-07	Kyle Crockett	Officer	Option exercise + sale	11,647 sold	$76.34	~$0.89M
2024-11-06	Kevin O'Connor	Officer	Option exercise + sale	167,183 sold	$73.46	~$12.3M
2026-01-30	Gitlin / Goris (CFO) / others	Executives	Stock awards (grants)	90,872 / 40,750 / smaller	$0	n/a

The other "D" entries with no description (Dryden, Pandya, Gierges, Heim) are probably tax withholding or holdings updates. The tool doesn't say.

Key takeaways - Viessmann is the dominant seller. He sold about 16.4M shares for about $1.05B over the past 12 months. Both sales were round-dollar amounts ($750M and $300M), which suggests block trades or secondary offerings. This is probably a stake received in the Viessmann deal being monetized (context). It is a supply and overhang issue more than a signal about operations. Another sale would add pressure, and the tools don't show what stake remains. - The sale prices are above today's price. The May 2026 sale at $62.01 is about 9% above the ~$56 price now, and the June 2025 sale at $70.30 is about 25% above. - The CEO bought with his own money in November 2025: 19,300 shares for about $1.0M at $52.62, near the lows. The stock is about 7% above that price now. It is a modest positive signal, but it is the only open-market insider purchase in the data. - No open-market officer selling since February 2025, apart from Viessmann. - The January 2026 equity grants were smaller than in February 2025: CEO 90,872 vs. 152,361 shares, CFO 40,750 vs. 49,395. The tools don't give the reason.

6. Actionable insights for traders¶

Bearish and risk factors 1. Earnings quality is deteriorating. Operating income fell 59% YoY in Q1 2026 on revenue that rose 2.4%, and Q3 2025 was also weak. This is the main reason the stock is below its averages. 2. The forward estimates look optimistic. Forward EPS of $3.31 against a recent quarterly run-rate of $0.28–0.50 needs a large margin recovery in H2 2026 and 2027. The upcoming Q3 report will test whether that is credible. Disappointment could push the stock toward the $50.24 low. 3. FCF and dividend coverage are thin. FCF was negative in Q1 2026, TTM FCF is about 1.9% of market cap, and the dividend uses roughly 90% of TTM FCF. 4. Leverage and liquidity are tight. The current ratio is about 1.0, cash is $1.4B, and current liabilities jumped $1.5B in a quarter. 5. A large holder has been selling. Another Viessmann block would likely pressure the stock. 6. Technical picture: The stock is below both averages with a 50-day/200-day death cross. The $50 level is the key support.

Bullish and mitigating factors 1. The CEO bought stock near $52.6. 2. Forward P/E of 17x is reasonable if earnings normalize, and the PEG is about 1.07. 3. Revenue has held up (+2.4% YoY in Q1 2026) and the TTM gross margin is a solid 24.7%. 4. Q1 is seasonally the weakest quarter, so part of the weak Q1 2026 cash flow is seasonal. The 9M 2025 FCF of $1.2B shows the H2 recovery pattern. 5. The Q1 2026 slowdown in financing outflows suggests management is conserving cash.

What to check next - Q2 2026 10-Q and the Q3 2026 earnings date. Find the cause of the Q1 operating income collapse (one-offs vs. structural) and whether guidance was cut. - Debt maturity schedule and the reason for the current liabilities jump. - Viessmann's remaining stake and any lock-up or selling plan. - Adjusted vs. GAAP EPS reconciliation, to judge whether $3.31 is achievable.

7. Summary table¶

Category	Key point	Evidence	Read
Data freshness	Latest financials are Q1 2026; Q2 2026 is missing and Q3 is pending	Statement columns end at 2026-03-31	Caution
Valuation	TTM P/E 40.8x vs. forward 17.0x; PEG 1.07; P/B 3.5x	Fundamentals snapshot	Mixed
Price trend	~$56.3, below the 50-day ($57.37) and 200-day ($61.75) averages; 27% below the high	Fundamentals snapshot	Bearish
Revenue	Q1 2026 $5.34B, +2.4% YoY; TTM $22.1B	Income statement	Neutral
Profitability	Q1 2026 operating income $259M (−59% YoY), margin 4.8%; EPS $0.28 vs. $0.47	Income statement	Bearish
Margins (TTM)	Gross 24.7%, operating 13.1%, net 5.5%; ROE 9.0%	Fundamentals snapshot	Mixed
Balance sheet	Assets $37.2B, liabilities $23.4B, equity $13.8B; cash $1.37B (from $3.97B)	Balance sheet	Caution
Liquidity	Current ratio ~1.0; current liabilities +$1.5B QoQ	Balance sheet	Caution
Leverage	D/E 0.92x; implied net debt/EBITDA roughly 3.5–4x (derived)	Fundamentals snapshot	Caution
Cash flow	Q1 2026 OCF $79M, FCF about −$15M vs. +$420M; TTM FCF ~$862M	Cash flow statement	Bearish
Capital returns	9M 2025 financing outflow −$3.9B; Q1 2026 only −$141M	Cash flow statement	Neutral
Dividend	Yield 1.71%; uses about 90% of TTM FCF (derived)	Fundamentals snapshot	Thin coverage
Insider selling	Viessmann sold 12.1M shares (~$750M) at $62.01 on 2026-05-20, and 4.27M (~$300M) at $70.30 in June 2025	Insider transactions	Overhang
Insider buying	CEO Gitlin bought 19,300 shares (~$1.0M) at $52.62 on 2025-11-25	Insider transactions	Mild positive
Key catalysts	Q3 2026 earnings (likely late October); explanation for the Q1 margin collapse; H2 FCF recovery	N/A	Event risk
Support and resistance	Support $50.24 (52-week low); resistance ~$57.4 (50-day), ~$61.7 (200-day)	Fundamentals snapshot	Technical levels

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for CARR: A Reset Stock Heading into a Catalyst

Thesis: At $56.27, CARR has been marked down about 26% from its June peak. It has had a downgrade and four target cuts in two weeks, and it sits in a base just before its Q3 print. The bar is low, the valuation is reasonable if earnings normalize, and the downside looks smaller than the upside.

1. The Street's bear case is mostly priced in¶

Firm	Action	Target	vs. $56.27
Stephens	Cut from $65	$55	-2%
Goldman	Downgrade to Neutral	$61	+8%
Bernstein	Cut from $78	$64	+14%
Mizuho	Cut from $75	$70	+24%
RBC	Cut from $82, still Outperform	$72	+28%

The average target of about $64.4 sits roughly 14% above the current price. The most bearish published target is essentially flat, and the downgrade itself still carries a target 8% higher. Estimates have been reset ahead of the print, so a merely "less bad" quarter can move the stock.

2. Valuation is not demanding¶

Forward P/E is 17x, with a PEG of about 1.07. The $64 Bernstein target is about 19x forward earnings.
I'm not hiding the GAAP gap. TTM GAAP EPS is $1.38 against $3.31 forward. These are almost certainly not like-for-like, because forward is adjusted. Q3 is what tests that bridge.
Risk/reward is skewed. Upside to the average target is about 14%. Downside to the September swing low (52.96 intraday) is about 6%, and to the ~$50 November low it is about 11%.

3. The business is not broken¶

Revenue is growing. Q1 2026 was up 2.4% and Q2 2025 up 3.0%. If Q1 profit collapsed on rising revenue, the problem is more likely cost, mix, timing, or one-offs than demand.
Earnings power has been shown. Operating margins were 15.0% in Q4 2024 and 14.8% in Q2 2025. TTM gross margin is 24.7% and TTM operating margin is 13.1%. Q1 2026's 4.8% is an outlier against that history.
Cash flow is seasonal and has been improving. Q1 is the weakest cash quarter. 9M 2025 free cash flow was about $1.2B against about $129M in 9M 2024, roughly 9x better, and the second half is when CARR generates cash.
The balance sheet has been repaired. Total liabilities are down from $28.9B (Q1 2024) to $23.4B after the large Viessmann deal. Q1 2026 financing outflows slowed to $141M, which looks like cash conservation.

4. The technicals describe a base forming¶

Higher low: The 10-14 close of 54.24 held above the 09-18 washout low of 53.88, even on downgrade day. Since then the stock is up about 3.7%.
Momentum has turned: The MACD histogram is positive, RSI has recovered from 32 to 52, and price is above the 10 EMA. OBV has rebounded from -102.5M to -78.9M.
Volatility is compressing: ATR has fallen from 1.84 to 1.38, and closes have held in a 53.88–56.37 range for five weeks.
The death cross is lagging. It printed on 9/24, after a 29% decline. The 50 SMA is falling toward price (61.82 → 57.23) and is only 1.7% above the close. A daily SuperTrend flip needs a close above 58.47, about 3.8% away.
The weekly and monthly z-scores are -0.95 and -0.92. Neither shows a statistically stretched breakdown.

5. Catalysts and conviction signals¶

Q3 earnings are imminent (date unconfirmed, but the advisory is out). After the target cuts, the bar is low.
The CEO bought $1M of stock at $52.62 in November 2025, within about 5% of the low. The stock then ran about 52% to the June high.
A $433M plant plan (headline only) suggests management is investing for growth.
The macro backdrop is not hostile. Prediction markets give an 8% US recession probability, an 86% chance of an October Fed hold, and hike odds down 18 points in a week.
Data-center cooling is a hot theme (the Trane upgrade and the ~50% backlog growth at Trane and JCI). CARR has data-center exposure (my context, not from the tools). Any evidence of that on the call could close the gap with peers.

Preempting the bear¶

"Q1 operating income was the lowest in the series." That is the strongest bear point, and I won't wave it away. But revenue grew, Q1 is seasonally weak, and TTM margins are far better. The cause matters, and it's what the print will tell us.

"The dividend eats about 90% of TTM FCF." That figure is derived, and TTM FCF is depressed by a seasonally weak Q1 that fell off a strong comp. The dividend is only a 1.7% yield, and the 9M 2025 FCF run-rate covers it comfortably.

"Viessmann keeps selling." Fair, since that is overhang. But his sales at $62.01 and $70.30 were above today's price, and the supply is a known technical factor, not an operating signal. The CEO is buying while the major holder is selling.

"Rates offer no relief." That is true, with 97% odds of no cuts in 2026. But a hold is already the consensus, and recession odds are low.

"Capital is rotating to Trane." That is a relative-performance argument, not an absolute one. It also makes CARR the laggard that catches up if its data-center commentary lands.

What I concede¶

The stock is below its 50 and 200 SMAs, all three SuperTrend tiers are down, and the weekly stop is 16% above. The tools also lack the Q2 filing, the Q1 explanation, and the earnings date. If Q3 shows a further margin slide or a guidance cut, I'd be wrong and $50 is in play. That is the risk I'm taking.

Questions for the bear¶

With an average target 14% above the price and the lowest target essentially at the price, what is the downside case beyond "the 50 SMA is falling"?
If revenue is growing 2–3%, why is Q1's margin collapse structural and not one-off or seasonal?
After a downgrade and four target cuts, what must go right on Q3 for you to be wrong? Bull Analyst: # Bull Rebuttal: I'll Give Up the Ground I Can't Hold

Your critique was good, and several of my numbers don't survive it. I'll concede those first, then show why the thesis still stands.

Where you're right¶

My claim	Verdict
13.1% TTM operating margin	Dropped. It doesn't tie to the GAAP quarters, and the fundamentals report flagged it as a different period or definition.
"H2 is when CARR generates cash"	Dropped. 2025 was Q1 $420M, Q2 $568M, Q3 $224M. That is front-loaded.
"Higher low" at 54.24	Downgraded. 0.36 points is about a quarter of an ATR. It's consolidation, not a confirmed higher low.
9x FCF improvement	Dropped. It was measured against the Viessmann-year trough.
CEO purchase as a conviction signal	Downgraded to mild positive. It's 11 months old and small.
Data-center catch-up, $433M plant	Optionality at best. The first is my own context and the second is a headline.
Balance-sheet repair	Finished in 2024 and flat since. It's not a catalyst, and I agree there's no slack.

I'm no longer arguing that CARR is a healthy business at a fair price. My claim is narrower.

Where your argument has holes¶

1. "The market bought into the cuts" has the logic backwards. The stock sits at the top of its five-week range, up 3.7% from downgrade-day close, after one downgrade and four target cuts. When bad news arrives and the price doesn't make a new low, that is what "priced in" looks like. I'll grant it's evidence, not proof, since the bounce came on average volume and the 10-21 bar is partial. You're right that my $64.4 average is a sample of the people who just cut. That is the point, though. The cutters' average target is still 16% above the price after their cuts.

2. Your derived Q4 numbers share an assumption you haven't defended. Your $1.19B Q4 operating income, −$87M Q4 net income and $85M Q4 FCF all assume the TTM window ends at Q1 2026. The fundamentals report says Q2 2026 is missing from the filings even though it should have been public since late July. If the snapshot's TTM includes Q2 2026, none of those derivations hold. Neither of us can tie out TTM without a quarter we can't see. I'll drop my 13.1% if you drop your three derived Q4 figures.

3. The market saw Q1 and bought anyway. Viessmann's block sold at $62.01 on 5/20. A 3/31 quarter's 10-Q is normally due about 40 days after quarter-end (my context), so Q1's 4.8% margin was almost certainly public by then. The stock then ran to $75.73 by 6/25, about 22% higher. If the July drop was the Q2 print, as you infer, then the damage came from what happened after Q1, and neither of us can see it. That makes Q2 and Q3 the real unknowns. "Unexplained" is not the same as "structural."

I won't claim Q1 was a one-off. I'll note that costs up 10.7% on revenue up 2.4% is a step-change, and revenue didn't fall first. Demand erosion usually shows up in revenue before margins. That points toward charges, mix or tariff timing, though I can't tell you which. The GAAP lines also don't move together: operating income −59%, net income −42%, EPS −40%. That is how lumpy items behave.

4. Your falsification bar is asymmetric. You'd be wrong only if Q3 operating margin returns to about 12%, Q1 is explained by non-recurring items, FCF is positive with H2 conversion reaffirmed, and the stock closes above $58.47. A "less bad" quarter fails that test by design. And "the stock will still be there at $58–60" contradicts your own evidence. Your best empirical datapoint is a 13.6% two-day gap. Gaps skip prices.

Your gap template points down to about $48.6.
The same gap pointing up lands at about $63.9, above the 200 SMA (61.51) and right at Bernstein's $64.
If the print is good, you won't get to buy at $58–60. You'll buy at $63 or higher, after the move.

You're right that +14% to a target and −6% to support aren't comparable. The honest framing is two roughly symmetric gaps, so the question is odds. The odds tilt mildly toward the upside because estimates have been reset, sentiment is already bearish (3.8/10, low confidence), and the stock has held above the 9/18 washout low through every negative headline. I'm claiming a tilt, not a lock. The July gap also started from $69, after a 52% run. Treating it as stationary assumes the same starting expectations, and those have been cut.

5. Smaller points. - The 80% hike odds. The macro report itself warned that the hike-count contracts appear to cover all of 2026 and shouldn't be read as hikes from here. October is 86% hold, FRED was down, and I'd call macro a wash. I agree rates are no tailwind. - Current liabilities. The $1.5B jump looks less alarming against Q1 2024, when current liabilities were $8.64B versus $8.59B now. That could be seasonal, though I don't have Q1 2025 to confirm. Liquidity is thin either way. - Viessmann. The overhang is real and his remaining stake is unknown. But $750M cleared at $62.01 and the stock then rose 22%. - OBV. I agree it's range-bound. The five-session rebound of about 24M more than reversed the roughly 18.5M of selling between 9/21 and 10/14. That removes a negative signal, but it isn't yet accumulation.

What I'm actually proposing¶

Size for the gap, not the stop. An earnings gap runs through stops. Size so a −14% print costs a tolerable amount (risk budget ÷ 0.14).
Start small. Add on a hold above the 10 EMA and Bollinger midline (about 55.4–55.5) or on a close above 58.47, and not before.
Judge Q3 on the adjusted bridge. Does $3.31 hold, and does the guide hold? GAAP year-over-year operating income is the wrong lens. The stock rose 52% off its November 2025 low through ugly GAAP prints.

What would make me wrong (you asked, so I'll answer): 1. A guidance cut, or full-year EPS guidance that can't support the $3.31 on which the 17x rests. 2. Q3 operating margin at or below Q1's level with no identified non-recurring items. 3. A close below 52.96 on heavy volume, which would end the base.

If those happen, I'm wrong and $48–50 is in play. If they don't, you'll be chasing a gap from $63. A stock with reset estimates, a defended washout low and a binary print is worth a sized starter position now, with more added on confirmation. Bull Analyst: # Bull Final Rebuttal: The Facts Are Mostly Agreed, So the Question Is Position Size

You've been fair, so I'll concede first, then say where I still disagree.

What I concede¶

Point	Verdict
Target cuts imply a lower bar	Unproven. The tools show five target changes and no EPS revisions.
3.8/10 sentiment as contrarian fuel	Dropped. It's three unlabeled posts, one about Trane.
The 0.36-point "held low" as an input to the odds	Dropped. It's consolidation, and I shouldn't count it twice.
Net-income conversion	Conceded. It was 92% in Q1 2026 and 79% in Q3 2025, against about 65% in Q1 and Q2 2025 (my arithmetic). Something below the operating line has cushioned EPS for two quarters. The operating line is the number to trust, and the headline EPS flatters it.
My kill criteria	Too loose. I adopt your two conditions.
$61–64 as supply	Real. It holds the 200 SMA (61.51) and the Viessmann block price (62.01). A good print probably stalls there before it extends.

Where I still disagree¶

1. "The market walked away from the recovery" is a measurement, and it works for me. The stock ran from 49.79 to 75.73, a gain of 25.94. It now sits at 56.27, so it has given back 75% of that rally (my arithmetic). It is only 6.9% above the 52.62 where the CEO bought. Only about a quarter of the recovery premium is still in the price. You're right that I can't prove this is an overshoot rather than an honest reset. But "priced in" doesn't assume the answer. It says that most of the optimism you're worried about has already left. If Q2 revealed something structural, that last quarter can go too, and that is the $50 scenario.

2. Target cuts leave two branches, and neither hurts me. - If analysts cut EPS, the Q3 bar is lower. - If they cut only multiples, the stock is cheaper on unchanged estimates.

Your rejoinder is that if estimates fall further, the 17x isn't real. That is a guide cut, and it's already one of my exit conditions.

3. Q3 is the easiest comparison in the table, and nobody has mentioned it. Q3 2025 had revenue down 6.8% and a 9.7% margin. Q1 2026 faced an easy revenue comp (−3.7%) but a tough margin comp (12.1%), and it still collapsed. Q3 2026 faces a depressed revenue base and a depressed margin base together. Your bar of "clearly above 9.7%" was cleared in five of the eight quarters shown and matched in a sixth. The only misses are Q1 2024, the deal-closing quarter (my context), and Q1 2026. That doesn't prove Q3 clears it, and the trend (12.8% → 9.7% → 4.8%) runs the wrong way. But clearing your test doesn't require a heroic recovery.

4. The median target is not an outlier story. The five targets are 55, 61, 64, 70 and 72, so the median of $64 is +14% and four of five sit at least 8% above the price. Goldman's roughly 10% total return is cost of equity for a 1.29-beta stock, which fits a Neutral rating. Stephens at $55 is the one outlier. One outlier doesn't move the median.

The cost of waiting, honestly¶

You shaded the miss to about −9%, and the clean-print landing zone is $61–64, which is +8% to +14%. At 50/50 that's an expected value of roughly +1 to +2.5%. A 55/45 tilt adds a point or so. That is a small edge, and I won't dress it up. It's why I'm proposing a small position and not a conviction buy.

Here is my case for owning something before the print. In the good branch, the confirmed buyer pays $61–64 into a zone that's both supply and roughly fair value on the sell-side's own numbers. That buyer gets certainty and loses most of the margin of safety. In the bad branch, a starter sized at risk budget ÷ 0.14 loses a bounded, pre-chosen amount. You're right that the information is valuable. But it arrives for everyone at the same moment, so the price of that information is the gap itself.

Agreed rules¶

I'm adopting your two conditions as the test:

I'm wrong, and I exit: Q3 operating margin at or below 9.7%, or a guide that can't support the $3.31 the 17x rests on. Either one is enough, whatever the headline EPS says.
I'm right, and I add: margin clearly above 9.7% with any one-offs identified, a guide that holds, and a daily close above 58.47.
Technical backstop: a close below 52.96 on heavy volume ends the base.

Bottom line¶

We agree on the macro, the thin balance sheet, the Viessmann overhang and the rebound-inside-a-downtrend picture. We also agree on what the print must show. The only open question is whether a bounded starter, about a third of the intended size, is worth carrying through a coin flip with a modest tilt. I think it is, because the loss is capped by sizing and the confirmed entry gives back most of the upside. If you want certainty first, that's a defensible choice, but it's a choice to pay up for it. I'd take the small seat now and let the print decide whether it grows. Bull Analyst: # Bull Closing Statement: A Smaller Case, a Better Entry

Most of your final round is right, so I'll concede it first.

What I concede¶

Point	Verdict
Targets as support	Dropped. The cutters' average went from $75 to $65.25, and the stock fell about 26%. Targets are still catching down. I'll use them only to mark where supply sits.
"Cheap"	Dropped. TTM P/E is 40.8x and the FCF yield is about 1.9%. The 17x forward multiple rests on an adjusted bridge I can't verify. It is a bet on that bridge, not a margin of safety.
EV table	Arithmetic is right. At 50/50 the edge is about −0.3% to +2.4%. A one-third starter makes that a tiny number.
Buying at the range top	Agreed. The 10-21 bar is partial, the close is at the upper band, and the daily z-score is +1.53. A market buy here has poor risk/reward.
My exit rule	Fixed. I wrote "at or below 9.7%." Your wording was "below." I'll use yours. A flat 9.7% would be stabilization after −3.1 and −7.3 point year-over-year steps. It is a hold, not an add.

Where I still disagree¶

1. A strict add rule doesn't make a good outcome less likely. My exit and add rules describe what I'll do. The price reaction depends on the print versus expectations. The stock can rise 8% on a print that misses my four-part add test, for example a beat against lowered consensus. Strict rules for adding and quick rules for cutting are how a starter keeps its loss defined. They don't narrow the odds of a good tape.

2. Break-even isn't 50%, because there's a middle. Your table treats the print as binary. A muddled print returns roughly zero. The condition then becomes P(clean) × gain ≥ P(miss) × loss:

At $61 against −10%, a clean print must be about 1.2x as likely as a miss.
At $64, the ratio is about 0.7x.
At the $62.5 midpoint, it is about 0.9x.

So the trade needs a clean print to be roughly as likely as a miss. I can't show it's more likely. The margin sequence (12.8% → 9.7% → 4.8%) argues against it, and the easy revenue base argues for it. Our evidence on that ratio is a wash, and that is the real disagreement between us.

3. The July gap is a weaker precedent than you make it. You said it "didn't stabilize." The technical report says mid-August closes were about 61–63, above the 59.92 post-gap close. The stock held for roughly three weeks. The September leg came on 13.3M and 21.4M-share days, and the tools don't name a cause. The report notes that the third-Friday timing fits options expiry or an index event, which is unverified. Attributing that leg to the July print is an inference stacked on an inference. I accept your narrower point that bad news isn't always priced on day one. That is why I want a small size and a pre-set exit.

4. The CEO's purchase wasn't pre-bad-news. The balance sheet dated 2025-09-30 is in the tools, and a 10-Q is due about 40 days after quarter-end (my context). So Q3 2025's 9.7% margin and −29% operating income were public when he bought on 11/25. That doesn't cover Q1 2026, which he hadn't seen. I'm not using the purchase as fair-value evidence. It only shows he bought after the first leg of the decline.

5. Your Q3 sensitivity runs one way. All three scenarios (6.1%, 4%, 2.4%) assume Q1's compression repeats. You have no mirror scenario where Q1 was lumpy and margins revert toward 12%. That is the very question neither of us can answer, so the sensitivity is an assumption, not evidence.

Revised proposal¶

Starter: at most one-third of intended size. Use a limit bid near 55.4–55.5 (10 EMA and Bollinger midline), not a market buy at 56.27. From 55.5, the 52.96 backstop is about −4.6% and the 58.47 flip is about +5.4%. If it doesn't fill and the stock clears 56.8, I don't chase. I'm in your camp until 58.47.
Size for the gap. Use roughly −10% to −11% as the loss, not the stop.
Exit: Q3 operating margin below 9.7%, a guide that can't support $3.31, or a close below 52.96 on heavy volume.
Add: margin clearly above 9.7% with one-offs identified, a guide that holds, and a daily close above 58.47.

Bottom line¶

We agree on the facts: the thin balance sheet, the Viessmann overhang, a rebound inside a downtrend, and what the print must show. The pre-print slice is the least important part of this position, and I won't oversell it. The edge is small, the loss is capped, and the price I'd pay is better than today's.

The reason to carry it is the good branch. A clean print likely gaps through $58.47 toward the $61–64 supply zone, and a confirmed buyer pays that. You've named that cost and accept it. If your mandate needs a demonstrable positive edge before the print, waiting is the defensible call. I'd bid 55.5, size for a 10% gap, and let the print decide whether it grows. Bull Analyst: # Bull Closing: Agreed on the Facts, Narrowed to Three Gates

You've argued this well, and on the narrow question of whether a pre-print starter has a demonstrable edge on today's record, my own table says no. I won't pretend otherwise. I'll concede what you've earned, push back where I think you overreach, and then state the position that's left.

What I concede¶

Point	Verdict
Resting bid at 55.5	Adverse selection is real. A limit order fills on touch and can't tell a held test from a failed one. The gain over 56.27 is also only 1.4%, so it never made this a different trade.
"Capped by sizing"	Budgeted, not bounded. Exits execute at gap prices, so only position size limits the loss. I'll size to the July template (about −14%, roughly $48 from 55.5), not −10% to −11%.
Inputs that tilted the odds	All dropped. I can't show P(clean) > P(miss).
Missing Q2	Fair for sizing. The side without the quarter should size smaller.

Where I still push back¶

1. "The market has read Q2 and we haven't" is an argument for homework, not abstention. The Q2 release and call are public, and the tools just didn't return them. The 26% drawdown shows what the market concluded, not whether it was right. Not knowing Q2 means we shouldn't size before reading it. It doesn't make the expected drift negative. Your "what would change my mind" list is the same list, and I agree with all of it.

2. The "fourth lower high" fails the noise standard you applied to me. The 10-21 high of 56.62 sits 0.17 below the 9/25 high of 56.79. That is about an eighth of an ATR, less than half the 0.36 "higher low" I conceded was noise, and it's on a partial bar. The sequence also mixes a close (57.46 on 9/11) with intraday highs and straddles the September washout. What the pattern does show is highs compressing against roughly flat lows while ATR falls from 1.84 to 1.38. That is a coil, and the print resolves it. I agree it isn't confirmation.

3. The "capped upside" is already in the table. The EV table lands the good branch at $61 and the bad branch at $50, both shelf-bounded, and both about 10% from 55.5. Penalizing supply again double-counts it. You've also said gaps skip prices, and that applies to $61–62 as much as to $53. The shelf matters for when I add, not for the starter's gain. Your point about a tail beyond $50 stands, and it's the reason for sizing to 14%.

4. Options cap the loss but don't create the edge. Pre-earnings premium is priced for the expected move, so a defined-risk structure buys certainty, not edge. I have no chain or implied move to evaluate it. I'll look at it, but I won't claim it fixes the EV.

What's left of the bull position¶

By my own numbers the starter is worth roughly zero to +1% on a third of a position, so it's an optional decision, not the thesis. Here is the gated version:

Gate 1, Q2 read: The release and call tie Q1's 4.8% margin to identified items, or show Q2 margin recovering. If Q2 is also mid-single-digit with no one-offs, I drop out of the pre-print position and agree with you.
Gate 2, implied move: Size the loss to the larger of 14% and the options-implied move. If the implied move is well below the −13.6% sample, the table improves. If it is above 14%, the starter shrinks accordingly.
Gate 3, entry: No resting bid. I buy only after a touch of 55.4–55.5 is followed by a daily close back above it, or on a close above 58.47. If neither triggers before the print, I own nothing going in and we end up in the same place.

If all three pass, I take a starter of at most one-third of intended size. If any fails, I take no position and wait for the print.

Post-print rules, which we now share: - Add: Q3 operating margin clearly above 9.7% with one-offs identified, a guide that supports the $3.31 the 17x rests on, and a daily close above 58.47. - Exit: Q3 operating margin below 9.7%, a trimmed guide, or a close below 52.96 on heavy volume.

Bottom line¶

My summary of the bull case now fits in three lines: 1. CARR is a reset stock, not a proven turnaround. About 75% of the rally has been given back, and Q3 faces an easy revenue comp. 2. It is not a buy at 56.27 and not a buy on target math. It is a buy on confirmation. 3. At most, a small, gated starter before the print is worth taking if Q2 checks out.

The gap between your "no bid" and my gated starter comes down to one hour with the Q2 filing. If that hour doesn't clear Gate 1, I'm at "no bid" too.

Bear Researcher¶

Bear Analyst: # Bear Case for CARR: A Cheap-Looking Stock With an Unexplained Earnings Collapse Before a Binary Print

I'll start with what we agree on: the stock has been marked down hard and the Q3 print is close. But several of your load-bearing numbers don't survive a check against the filings, and your concessions section is really the whole thesis.

1. "Priced in" is the weakest pillar¶

Targets aren't a floor. The four analysts who cut went from an average target of $75 to $65.25, a 13% reduction. Since the downgrade-day close, the stock is up 3.7%. The market bought into the cuts, which is the opposite of "already priced."
Your $64.4 average is a sample of the analysts who just cut. The tools show no upgrades or raises. Stephens is at the price, and Goldman's Neutral says an 8% target isn't enough to own it.
"17x forward" assumes $3.31 is still the number. Cuts of 7–18% mean estimates, multiples, or both are falling. If E drops, the multiple rises.
The stock has already round-tripped 75% of its rally. It went from $49.79 to $75.73 and is now at $56.27. The market is un-doing the recovery thesis the CEO's purchase was betting on.

2. Q1 is not an outlier¶

Quarter	Op margin, prior year	Op margin, this year
Q3	12.8%	9.7% (op income −29%)
Q1	12.1%	4.8% (op income −59%)

Seasonality is already in a YoY comparison. Q1 2025 was 12.1%, so "Q1 is seasonally weak" doesn't explain 4.8%.
Revenue "growth" is thin. Q1's +2.4% came off a −3.7% comp, and 5,341 is still below Q1 2024's 5,420. Revenue rose $123M while implied costs rose $493M (+10.7%). You listed "cost, mix, timing, or one-offs." Only one of those is benign, and you don't know which it is.
Your 13.1% TTM operating margin doesn't tie to the filings. To reach it, Q4 2025 would need about $1.19B of operating income, roughly a 23% margin, against a best-ever quarter of $903M. The three verifiable quarters since Q2 2025 average about 10.0%, and that includes the seasonal peak. TTM net income also implies Q4 2025 was about −$87M. That's low confidence, but it points the same way.
You're missing the market's verdict on Q2. On 7/28–7/29 the stock fell 8.9% and then 5.1% on about 16.5M shares each day, 13.6% in total. The tools don't name the cause, but the timing fits the Q2 print (my inference). Your "outlier" thesis rests on data that stops before that reaction.

3. Cash flow: your seasonality claim contradicts the table¶

2025 free cash flow was front-loaded. Q1 was $420M, Q2 $568M, and Q3 $224M. TTM FCF of $862M implies Q4 2025 was only about $85M (derived). That puts H2 at roughly $309M against $988M in H1. The "second half generates the cash" story isn't in the numbers.
Q1 2025 was +$420M, so Q1 2026's −$15M is a $435M swing and not a seasonal excuse. Capex also rose 49%.
The "9x improvement" compares against the Viessmann-year trough ($129M in 9M 2024).
The dividend takes about 92% of TTM FCF (roughly $0.8B, derived). The $433M plant plan is about half of TTM FCF, though we don't know the timeline. I'm not predicting a dividend cut. The point is there's no slack if H2 disappoints.

4. The balance sheet repair stopped a year ago¶

Total liabilities were $23.0B at 12/31/24 and are $23.4B now. Cash fell from $3.97B to $1.37B and equity fell $0.6B.
The 2024 deleveraging looks asset-sale-funded, not earnings-funded. The $2.3B one-time gain in Q2 2024 is the tell (my inference).
The current ratio is about 1.05, current liabilities jumped $1.5B in one quarter, and implied net leverage is about 3.7x reported EBITDA (derived; adjusted would be lower).
"Financing outflows slowed to $141M" isn't discipline. After −$2.7B in Q1 2025 and with FCF at −$15M, it reads as lack of capacity.

5. The technical "base" is thinner than it looks¶

The "higher low" is 0.36 points, about a quarter of one ATR (1.38). That's noise.
OBV made a lower low on 10-14 (−102.5M) than in September (about −90.8M) while price made a higher low. That is a distribution signal. The rebound only returned OBV to its range, with a net gain of about 5M over 30 days.
The bounce is low quality. MACD is still below zero, RSI at 52 is only neutral, and the 10-20 gain came on average volume. The 10-21 bar is a partial session, so the 3.7% bounce and the "top of range" reading could change.
The 10-21 high (56.62) is below the 9/25 high (56.79). The close is at the upper Bollinger Band with a daily z-score of +1.53.
The 50 SMA is falling toward price mechanically. A reclaim on that drift isn't a signal. Even then the 200 SMA is 9.3% away and the weekly SuperTrend stop is 19% away.
Weekly and monthly z-scores near −0.9 cut both ways. A stock that isn't stretched has no mean-reversion cushion.

6. The "conviction signals"¶

The CEO's purchase is 11 months old. It was $1.02M, 19,300 shares, against a 90,872-share grant in January. The tools show no purchase when the stock re-tested $53 on 21M shares in September. "CEO buying while Viessmann sells" isn't concurrent. I'll concede that Viessmann sold at $62 before the run to $75.73, so his timing isn't a signal. His remaining stake is still unknown overhang.
The data-center catch-up thesis runs against the evidence. By your own admission it's "my context, not from the tools." The tools show the same Goldman note that downgraded CARR upgraded Trane, citing roughly 50% backlog growth, and also downgraded Lennox. The street is putting CARR on the wrong side of the mix. Laggards lag for reasons.
Rates offer no relief. The market gives 97% odds of no cuts and 80% odds of another hike by the December meeting, with the FOMC on Oct 28–29. The tape is risk-on and tech-led, not industrial-led.
The $433M plant plan is headline-only and arrives with falling profit and negative Q1 FCF.

Risk/reward¶

Your +14% is a 12-month sell-side target. Your −6% to −11% is a support level. Those aren't comparable. The empirical event risk is the last gap, 13.6% in two days, which from here is about $48.6, below the $49.79 closing low. The upside needs a margin recovery and a clean guide. The downside needs one more miss.

Your three questions¶

Downside beyond the 50 SMA: the earnings trajectory. A guide cut leads to estimate cuts, the $3.31 shrinks, the multiple expands, and $48–50 comes into play.
Why structural? I don't have to prove it. You have to prove it's one-off, and you can't. Q3 2025 was weak, Q4 2025 looks weak by derivation, Q1 2026 is the lowest operating income in the series, and Q2 2026 is invisible.
What would make me wrong? Q3 operating margin back near 12% or better (against 9.7% a year ago), Q1 explained by identified non-recurring items, positive FCF with H2 cash conversion reaffirmed, and a daily close above $58.47.

Bottom line¶

You're asking us to buy a "less bad" print on a stock whose last quarterly profit collapse is unexplained, whose cash flow is falling, whose peers are winning the mix shift, and whose rebound is volume-unconfirmed. Stand aside into the print. If the evidence arrives, the stock will still be there at $58–60. Bear Analyst: # Bear Rebuttal: The Argument Has Narrowed to One Real Disagreement

You've given up most of the fundamental ground, so I'll do the same where you've earned it. Then I'll explain why what's left still argues for waiting.

What I'll concede¶

My claim	Verdict
Derived Q4 2025 figures (op income, net income, FCF)	Conditional. They assume the TTM window ends at Q1 2026, and with Q2 2026 missing I can't prove that. I'll stop leaning on them.
"80% odds of another hike by December"	Dropped. Those contracts may cover all of 2026. I can stand on 97% no cuts and 86% October hold. Macro is a wash.
Current liabilities +$1.5B	Unresolved. Q1 2024 was $8.64B against $8.59B now, so it may be seasonal. Liquidity is thin either way (current ratio ~1.05, cash $1.37B).
"It'll still be there at $58–60"	Overstated. Gaps skip prices.
A −13.6% gap as my template	Shade it. July started from an elevated base after a 52% run. A miss from here is more like −9% (~$51), though the mirror-image beat is +9% (~$61).
"Q1 was unexplained, so the market must have disliked it"	Wrong. The market looked through Q1 and bought.

On the 13.1% swap, I don't need to trade. It fails under both windows. It implies ~$2.9B of TTM operating income. If the window ends at Q1 2026, Q4 2025 would need ~$1.19B. If it ends at Q2 2026, Q4 2025 plus Q2 2026 would need ~$2.1B, against $1.68B for the same two quarters a year earlier (774 + 903). That is +25% in a year when Q1 fell 59%. It's probably a different definition, as the fundamentals report suspected.

What still stands¶

1. Your "market looked through Q1" point cuts against you. The stock ran from $62 to $75.73 with Q1 public, so the market was underwriting an adjusted-earnings recovery. Then it gave back all of it and more, starting 7/28. The tools don't name the cause, but the timing fits the Q2 print (my inference). The recovery thesis was tested after Q1 and the market walked away from it. Whether $56 is an overshoot or an honest reset is the open question, and "priced in" assumes the answer.

2. Target cuts are not estimate cuts. Your claim that the bar is lower rests on estimates being reset. The tools show five target changes and no EPS revisions. If analysts cut multiples and left $3.31 alone, nothing about the Q3 bar moved. I also can't verify that the 17x forward P/E is on post-cut numbers.

Targets above price are the default state of sell-side coverage, so "16% above" after the cuts says little. Look at the two outliers on a total-return basis: - Goldman's $61 is +8% plus a 1.7% yield, about 10% over twelve months. That is roughly the cost of equity for a 1.29-beta stock, which is why it's Neutral. - Stephens' $55 is about zero total return.

3. "Lumpy" doesn't mean "one-off." Operating income fell 59%, net income 42%, and EPS 40%. That divergence shows the bottom line was cushioned, not that the operating hit was transitory. Q1 2026 net income was 92% of operating income, against about 65% in Q1 and Q2 2025. At a normal conversion, $259M of operating income yields about $170M of net income, not $238M. Something below the operating line added roughly $70M, or about $0.08 of the $0.28 (my arithmetic, rough). The headline EPS is the flattering lens.

Costs rose $493M on revenue up 2.4%, and price-cost squeeze and mix also show up in margins before revenue. Neither is a one-off. I'll still say plainly that I can't prove which one it was, and neither can you.

4. Your "tilt" has three legs, and you've already weakened each. - The held low. You downgraded 0.36 points (about a quarter of an ATR) to "consolidation," then counted it again in the odds. - Bearish sentiment as contrarian fuel. The 3.8/10 reading comes from three unlabeled posts, one of which is about Trane. The sentiment report calls it an echo of the Goldman event and says Reddit is disabled. - Reset estimates. See point 2. Unproven.

Meanwhile the bounce is a retest of the 56.5–56.8 ceiling on partial-session, average-volume data, and the 10-21 high is still below 9/25's. A stock that didn't make a new low hasn't been shown to be priced in.

5. Your own upside case lands on the target. A mirror-image gap puts CARR at about $63.9. That is Bernstein's $64 and just above the 200 SMA (61.51). The average target is $64.4. In your good scenario the stock arrives at the sell-side's fair value, and block buyers from Viessmann's $62.01 sale, now ~9% underwater (my inference), sit in that same zone. The payoff is roughly ±14%, so the whole trade is the tilt. That tilt rests on the three legs above, so it isn't established.

Your falsification bar is the loose one¶

You say my bar was too strict, and I accept that. Four conditions joined by "and" was too many. But yours is only triggered by disaster. Q3 operating margin "at or below Q1's 4.8%" means a drop of five points from last year's 9.7%. A Q3 at 8% would be a third visible year-over-year margin decline (Q3 2025, Q1 2026, Q3 2026), and it would trigger none of your kill criteria.

I'll replace mine with two conditions: 1. Q3 operating margin clearly above 9.7%, with any one-offs identified. 2. A guide that supports the $3.31 the 17x rests on.

If both hold, I'm wrong about the quality of the business. If margin is below 9.7% or the guide is trimmed, you should be out whatever the headline says. Anything between those cases is a muddled print, and muddled prints on a stock that has fallen 13% in two days before are not obviously friendly.

Where we actually disagree¶

We now agree on almost everything operational: - Size for the gap, not the stop. - Add on a close above 58.47 or a hold above the 10 EMA and Bollinger midline. - The macro is a wash, the balance sheet has no slack, and the technical setup is a rebound inside a downtrend.

The only real difference is whether to own a starter position before the print. Your plan already says confirmation matters, since you'd add only on a hold or a 58.47 close. If so, the information arriving in days is worth more than the risk premium for being early, because you are buying a coin flip with a modest tilt you've described yourself as "not a lock."

Waiting has a cost, and I'll state it. If the print is good, I pay $61–64 instead of $56, and I give up 8–13% of upside. I accept that price. In return I find out what happened in Q2, why Q1 was 4.8%, and whether $3.31 survives, which are the three things neither of us can see from here. A 14% loss on the other side of the same coin would take a long time to earn back at the 8–10% total return the cautious analysts are offering.

My position hasn't changed. Don't buy CARR before the print, and let the print earn the position. Bear Analyst: # Bear Final Rebuttal: Apply Your Own Rules and the Starter Fails

You've been straight about the evidence, so I'll start with what you've earned.

What I concede¶

Point	Verdict
75% of the rally has been given back	Correct. 19.46 of 25.94. Optimism has been marked down.
9.7% was cleared in five of eight quarters	Correct. In a normal year it isn't a heroic bar.
"The information arrives for everyone at once"	Correct. The price of waiting is the gap, and I've said I'll pay it.
Median target $64, four of five at least 8% above	Correct arithmetic.

The remaining dispute is whether these facts amount to an edge worth carrying through the print. I don't think they do.

1. Your rules make "exit" bigger than "add"¶

You adopted a disjunctive exit: margin at or below 9.7% or a guide that can't support $3.31. You adopted a conjunctive add: margin clearly above 9.7%, one-offs identified, a guide that holds, and a close above 58.47. More of the outcome space ends in exit than in add by construction.

Two consequences: - A flat print is an exit. The Q3 margin you call an easy bar, 9.7% again, triggers your own exit rule. Staying in requires real margin expansion in a year when Q1's margin fell 7.3 points. - "Clean" is the narrow branch. It needs several conditions to hit at once, so treating it as a coin flip is generous.

2. The expected-value math doesn't survive your own range¶

You quoted +1% to +2.5% at 50/50. That uses the middle and top of your landing zone and drops the bottom.

Good-branch landing	vs. $56.27	EV at 50/50 vs. a −9% miss	Break-even P(good)
$61 (Goldman, 200 SMA, Viessmann block)	+8.4%	about −0.3%	~52%
$64 (Bernstein)	+13.7%	about +2.4%	~40%

Your supply concession caps the upside. You granted that $61–64 is supply and that a good print "probably stalls there." That makes the lower row the realistic one.
The bad branch has a longer tail. You've said $50 is in play if Q2 revealed something structural. That is −11.5% (my arithmetic), not −9%, and at $61 it pushes EV below −1.5%.
The stake is tiny. A +1% EV on a one-third starter is about +0.33% of the intended position. Each 5-point swing in P(good) moves it by about a point. Your tilt rested on sentiment, the held low and the estimate resets, and you've dropped all three.
The technical risk/reward is no better. Your backstop (52.96) is 5.9% below. The first confirmation level (58.47) is 3.9% above, with the range ceiling and the 50 SMA in between.

3. An easy comp is not protection¶

You say Q3 2026 faces a depressed revenue base and a depressed margin base. Q1 2026 had the same easy revenue comp (−3.7%) and the margin still fell from 12.1% to 4.8%. Your bar is also a level (9.7%), not a year-over-year change.

An illustrative sensitivity on Q3 2025's 9.7% (my arithmetic, not a forecast):

Repeat half of Q1's compression (−3.65 pts): about 6.1%.
Apply Q1's proportional decline in operating income (−59%): about 4%.
Repeat the full −7.3 pts: about 2.4%.

Clearing 9.7% therefore needs nearly all of Q1's hit to have been transitory. You've said you won't claim Q1 was a one-off, and Q2 is invisible to us both. The five-of-eight base rate also ends with 9.7% and then 4.8%. The latest data points are the ones that matter.

4. The November anchors predate the bad news¶

The 49.79 low and the CEO's $52.62 purchase were both set in late November 2025. That was before Q1's 4.8% margin and before the July gap.

The CEO bought a business earning 9.7% margins. The latest quarter we can see is 4.8%. The stock is still 13% above that closing low, so distance from an old anchor says little about distance from fair value.
The last gap didn't stabilize. From 69.33 the stock fell 13.6% in two days. It then fell another 10% from 59.92 to the 53.88 washout, with 13.3M and 21.4M-share days. That is about −22% from pre-print to the low. The cause is my inference from the timing, but the pattern holds: the one earnings gap in our data repriced over seven weeks and did not mean-revert in a day.
That favors waiting. It argues that a bad print is not fully priced on day one, and buying after confirmation avoided a further 10% last time. I can't say a good print drifts the same way.

5. Targets are still catching down¶

Your median is fine, but the four cutters took their average target from $75 to $65.25, a cut of 13%. The stock fell about 26% from its June peak. The cuts closed roughly half the gap. The next round of marks comes after the print, so a median target is a survey of analysts who haven't yet seen the number that matters.

On "neither branch hurts me": neither branch helps either. A lower EPS bar only pays if the print clears it, and a multiples-only cut isn't "cheaper on unchanged estimates." It is the sell-side saying the stock deserves a lower multiple.

The "cheap" case also rests on one metric, 17x forward on adjusted EPS. TTM GAAP P/E is 40.8x, price/book is 3.5x, and the FCF yield is about 1.9%, so the dividend takes about 90% of it. You've agreed the operating line is the number to trust, and the forward P/E doesn't tie to it.

Where this leaves us¶

We agree on the macro, the thin balance sheet, the Viessmann overhang, and a rebound inside a downtrend. We also agree on what the print must show. Applying those rules honestly, a position before the print is a bet that a multi-condition "clean" outcome arrives. The payoff is capped near $61–62 by supply you've conceded. The downside runs to $50, and the last gap took weeks to finish.

The edge is about a third of a percent of the intended position, and the inputs that produced it are gone. I'd rather pay the cost I've already named, 8–13% of upside on a clean print, and buy once Q2, Q1's cause and $3.31 are visible.

My position is unchanged. Don't open before the print, and if you hold CARR, the same logic argues for smaller, not larger. Let the print earn the position. Bear Analyst: # Bear Closing: The Starter Prices at Roughly Zero

You've dropped the "cheap" claim, the target-support claim, the sentiment tilt, the held-low tilt and the loose exit. The remaining proposal is a one-third starter that you call "the least important part of this position," with an edge you say you "can't show." I'll concede what you've earned, then explain why that is a reason to pass.

What I concede¶

Point	Verdict
Limit bid at 55.5 vs. market buy	A real improvement. From 55.5, $61 is +9.9% and $50 is about −9.9% (my arithmetic). The break-even ratio at $61 falls from ~1.2 to ~1.0.
"The July gap didn't stabilize"	Overstated. Mid-August closes of ~61–63 were above the 59.92 post-gap close.
September leg tied to the print	Dropped. It was an inference stacked on an inference.
My Q3 margin sensitivity	Illustration, not evidence. Your mirror case (reversion toward 12%) is equally an assumption.
Rules vs. price	Fair. Your add and exit rules govern what you do, not how the tape reacts. A beat against lowered consensus can rally on a print that fails your add test.
CEO timing	My heading was too strong. Q3 2025's 9.7% margin was public when he bought. He hadn't seen Q1 2026's 4.8%.

Where I still disagree¶

1. "A wash" is not neutral, because the market has read Q2 and we haven't. You say the margin trend argues one way and the easy comp the other. We are both missing Q2 2026, but the market isn't. The fundamentals report says it should have been filed by now. With that quarter public, the stock fell about 26% from its peak. Five firms with full models cut or downgraded in two weeks, and the tools show no raises. You've also dropped every input that tilted the odds up: sentiment, the held low, estimate resets and "cheap." What's left is a ratio you can't show exceeds 1. The side with the missing quarter should demand a larger edge, not accept a smaller one.

2. The tape has been selling its bounces. The post-gap bounce to ~61–63 in mid-August was followed by a drop of roughly 12–15% to the 9/18 low (my arithmetic). Each rally since has topped lower: ~61–63 in August, then the 9/11 close of 57.46, the 9/25 high of 56.79, and 56.62 so far on a partial bar. You've agreed this is a rebound inside a downtrend. Starting a position into the fourth lower high isn't confirmation, and your own plan says to wait for confirmation before adding.

3. "Capped by sizing" means "budgeted by assumption." Your exit rules can only execute after the gap, at gap prices. The only earnings-timed gap in our sample was −13.6% in two days, and the stock then fell about 22% to its low (my arithmetic). Budgeting 10–11% puts you at the gentle end of that range. A July-sized gap would exceed the budget by roughly a quarter to a third. The −4.6% stop and +5.4% flip in your proposal are stop math, which you already said doesn't apply to a gap. If the aim is a loss that is actually bounded, that is what a defined-risk option structure is for. The tools gave no implied move or chain, so I can't say whether it's cheap, but that is the right instrument for the question.

4. The bid fills at the level whose loss is the failure signal. The technical report treats a loss of the 10 EMA (55.50) and Bollinger middle (55.41) as the sign the bounce has failed. Your add rule treats a hold above those levels as constructive. A bid at 55.5 fills when price tests that level, before you know whether it holds. If the bounce works, you don't fill and you're in my camp. If it fails, you own the stock as the technicals turn. That is a mild adverse selection, but it points the wrong way.

5. The upside is capped where the downside isn't. You've conceded that $61–62 is supply (the 200 SMA, the Viessmann block price and Goldman's target). The first move on a clean print probably stalls there. The loss side has no equivalent shelf above $50 in your own analysis. A trade with a capped good branch and an uncapped bad branch needs a clear probability lead, and you've said you don't have one.

What would change my mind before the print¶

Read the Q2 release and call transcript. They're public and the tools didn't return them. If Q1's 4.8% is tied to identified one-offs and Q2 shows recovery, the ratio moves and I'll rerun the table.
Get the options-implied move. Your table assumes a gap of −9% to −11% from one sample. The market's own estimate is a better input.
A close above 58.47 before the print would be market confirmation. It's your add condition, and I'd accept it as mine.

Bottom line¶

We agree on the facts: thin liquidity, Viessmann overhang, a rebound inside a downtrend, and the conditions the print must meet. You've also priced the trade honestly. It sits at roughly zero expected value. Your own number puts it at −0.3% to +2.4% at a 50/50 split, and you can't show the odds are better. The upside is capped by supply, the loss is budgeted rather than bounded, and the missing information is cheap to get and arrives within days. You wrote that waiting is the defensible call if the mandate needs a demonstrable edge before the print. That is my mandate, and your own table shows the starter doesn't meet it.

I'd place no bid before the print and let the print earn the position. Bear Analyst: # Bear Closing: Take the Gates, Keep the Pass

You've cut your case down to three gates and a starter you call "optional, not the thesis." I'd have written two of those gates myself, so I'll concede what you've earned and then isolate the one piece I still can't accept.

What I concede¶

Point	Verdict
"Fourth lower high"	Dropped. The 10-21 high of 56.62 sits 0.17 below 9/25, about an eighth of an ATR, on a partial bar, and my sequence mixed a close with intraday highs. What survives is narrower: no close above 56.37 in five weeks. That is a ceiling, not a trend.
Options	Agreed. I raised them to bound the loss, not to create edge. Premium prices the expected move, and I have no chain to judge it.
Supply double-counted	Fair. I chose the $61 row because of the supply, so I shouldn't charge for it again elsewhere.
"Homework, not abstention"	Fair. Reading Q2 is the right next step, and "no bid before the print" is compatible with it.
Gate 2 sizing	Agreed. Size to the larger of 14% and the implied move.

Where I still disagree¶

1. Gate 3 has two legs, and only one carries information. - The close above 58.47. I already said I'd accept this as market confirmation. It's about 1.6 ATR away (2.20 vs. 1.38) and flips the daily SuperTrend. - The retest-and-reclaim at 55.4–55.5. That is about 0.56 ATR below the close and inside a five-week range (53.88–56.37). A touch followed by a close back above is routine inside that range and says nothing about the print.

The retest leg is the one that will fire in an ordinary week, so the "gated starter" is mostly a dip-buy inside a range. By your own table, that trade is worth roughly zero.

2. Gate 1 can't create an edge on its own. The market has read Q2 and priced it, and the stock is down about 26% from its peak. Passing the gate only moves our probability of a clean print relative to the market's if we interpret the quarter differently. Your passing condition, Q2 margin recovering, also sits awkwardly with the 13.6% two-day gap on 7/28–7/29. I inferred that gap was the Q2 print, and it's unverified. If margin recovered and the stock still fell, the damage came from guidance. So the gate should test whether you can explain why the market is wrong, not whether Q2 was acceptable. That means reading: - the FY26 guidance change on the Q2 call; - whether $3.31 is FY26, NTM or FY27, which the fundamentals report doesn't say and which changes what 17x means; - the consensus EPS history, since the tools show five target changes and no EPS revisions.

3. The timing squeezes the gates. Carrier has historically reported Q3 in late October (context), and the FOMC meets Oct 28–29. You have days, not weeks, for a multi-condition filter to fire. In practice it will most likely trigger the retest leg and nothing else.

What I'll commit to¶

Pre-print: I hold no position. If Gates 1 and 2 pass and CARR closes above 58.47 before the print, I won't object to your starter. That is the confirmation I named earlier.
Post-print: I adopt the shared rules.
Add on Q3 operating margin clearly above 9.7% with one-offs identified, a guide that supports the $3.31, and a close above 58.47.
Exit on margin below 9.7%, a trimmed guide, or a heavy-volume close below 52.96.
If you already own it, the same logic argues for smaller, not larger.

Bottom line¶

We now agree on the facts: thin liquidity, Viessmann overhang, a rebound inside a downtrend, and what the print must show. The only open question is whether a retest inside a five-week range deserves capital ahead of a binary event.

My answer is no. The expected value is about zero, the upside stalls at the $61–62 supply you've conceded, and the tail runs to $48–50 at gap prices. The missing information arrives within days for everyone at once.

Don't buy CARR on the retest. Buy it on the 58.47 close or after the print, and let the evidence earn the position.

Research Manager¶

Recommendation: Underweight

Rationale: This debate ended almost entirely on the bear's terms, so I'm not calling it a Hold. The bull opened with a value-plus-catalyst thesis: 17x forward, an average target about 14% above the price, a basing chart and a low bar into Q3. By the final round the bull had dropped nearly every leg of that. The 'cheap' claim went once TTM GAAP P/E (40.8x) and the ~1.9% FCF yield were on the table. Targets stopped counting as support because they are cuts, not EPS revisions, and are still catching down. The 3.8/10 sentiment reading went, as did the 0.36-point 'higher low', the H2 cash-generation claim, the 13.1% TTM margin and the 9x FCF comparison. The bull ended up at a gated, optional one-third starter and admitted it was worth roughly zero to +1% EV on their own numbers, with no showing that a clean print is more likely than a miss.

The bear's fundamental points stood unrebutted: - Margins: Operating margin went from 12.8% to 9.7% (Q3) and from 12.1% to 4.8% (Q1) year on year. That is a YoY comparison, so seasonality doesn't explain it. - Costs: Costs rose about 10.7% on revenue up 2.4%. - Earnings quality: Net income ran at roughly 92% of operating income in Q1 2026, which cushioned headline EPS. The operating line is the number to trust, and it is deteriorating. - Cash: 2025 FCF was front-loaded and Q1 2026 FCF was -$15M. The dividend absorbs about 90% of TTM FCF. - Balance sheet: Cash fell from $3.97B to $1.37B and the current ratio is about 1.05. Liabilities have been flat since the 2024 repair, so there is no slack. - Information gap: The market has read Q2 2026 and we haven't. Since then it has taken the stock down about 26% from the peak, and five firms have cut targets or downgraded with no raises.

The payoff is skewed the wrong way. A clean print likely stalls in the $61–64 supply zone (200 SMA 61.51, Viessmann block at $62.01, Goldman $61, Bernstein $64). A miss can run to $48–50 at gap prices, and the only earnings-timed gap in the sample was -13.6% in two days. Exits can't protect against that, so sizing is the only real control.

The bull still earned some credit, which is why this is Underweight and not Sell: - About 75% of the rally has already been given back. - Q3 laps a depressed 9.7% margin and a -6.8% revenue base. That bar was cleared in five of eight quarters. - Q1 may turn out to contain identifiable one-offs. - Gaps skip prices, so waiting could cost 8–13% if the print is clean.

Those points argue against a full exit. They don't justify carrying full or larger exposure into a binary print with roughly zero EV and a fatter left tail.

Several things are missing from the evidence: - the Q2 2026 filing and call; - the cause of Q1's 4.8% margin; - the confirmed Q3 earnings date; - the options-implied move; - the consensus EPS revision history; - whether $3.31 is FY26, NTM or FY27.

Any of these could change the picture, and the conclusion is conditional on them.

Strategic Actions: 1) Trim, don't add. Bring CARR to roughly half of a standard allocation into the Q3 print. Reduce further if your risk budget can't absorb a -14% overnight gap on the residual. Size so that the larger of 14% and the options-implied move (once obtained) is a tolerable loss, and assume the tail runs to about $48. Execute trims into strength inside the 56.4–56.8 range ceiling; don't sell into weakness near 53–54. For accounts with no position, stay flat.

2) No pre-print buying. Don't buy at 56.27, and don't buy on a retest or reclaim of 55.4–55.5. That move is routine inside the five-week 53.88–56.37 range and carries no information. Place no resting limit bids.

3) Homework before the print, in days, not weeks. Pull the Q2 2026 release and call transcript, and check: - what FY26 guidance changed, and whether Q1's margin is tied to identified non-recurring items; - which period $3.31 refers to; - the consensus EPS revision history; - the options-implied move; - the confirmed earnings date.

The FOMC meets Oct 28–29, so be aware of event overlap.

4) Single pre-print exception. If the Q2 read clearly explains Q1 as one-off or shows margin recovery, and CARR closes above 58.47 (daily SuperTrend flip) before the print, you may restore toward a standard allocation. That size must still respect the 14%/implied-move gap budget.

5) Post-print upgrade path. Rebuild to a standard allocation only if all three hold: - Q3 operating margin is clearly above 9.7%, with any one-offs identified; - the guide supports roughly $3.31; - a daily close prints above 58.47.

Expect supply at $61–64. Add in tranches on a hold through that zone rather than chasing the gap.

6) Post-print exit path. Exit the residual entirely if any one occurs: - Q3 operating margin comes in below 9.7%; - full-year guidance is trimmed or can't support $3.31; - a heavy-volume daily close lands below 52.96.

7) Muddled print (margin roughly flat near 9.7%, guide intact but unconvincing): stay at the reduced weight and reassess after the post-print estimate and target revisions settle.

8) Overhang. Monitor for further Viessmann sales, since his remaining stake is unknown supply, and avoid adding into any announced block.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The research plan is Underweight, which maps to a Sell as a trim rather than a full exit. The higher-timeframe structure is bearish: SuperTrend is down on all three tiers, price is below the 50 SMA (57.23) and 200 SMA (61.51), and the death cross occurred on 09-24. The current bounce to 56.27 is a counter-trend rebound at the top of the 53.88-56.37 range, at the upper Bollinger Band (56.54), and 3.8% under the daily SuperTrend flip at 58.47. Fundamentals also point down: operating margin is compressing, FCF is thin, and the plan sees a clean Q3 print stalling at $61-64 while a miss could gap to $48-50. A trim into strength is better than selling into weakness. The residual should be exited on a heavy-volume daily close below 52.96, the 09-18 intraday swing low. A daily close above 58.47 combined with a clean Q2 read would invalidate the bearish stance. The Q2 2026 filing, the confirmed earnings date, and the options-implied move are not in the evidence and should be checked before the print.

Entry Price: 56.6

Stop Loss: 52.96

Position Sizing: Trim to about half of a standard allocation before the Q3 print, executing into strength at 56.4-56.8 and not selling into weakness near 53-54. Reduce further if the residual cannot absorb a -14% overnight gap (to about $48). Size for the larger of 14% or the options-implied move once obtained. Accounts with no position stay flat and place no pre-print buy orders. Restore toward standard weight only after the Q2 read explains Q1's margin and a daily close above 58.47, or after a clean Q3 print.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: I'll go first, so I'll take on the objections I expect from both of you. The Sell, a trim to about half at 56.4 to 56.8, is the bold call here, not the timid one. After a 29% slide from the June peak and a fresh 3.7% bounce off 54.24, the crowd either says "it's washed out, buy" or "just wait for the print." This plan sells the bounce, ahead of the event, without waiting for confirmation, and it still states exactly where it's wrong.

Start with the bounce itself. The 10-20 gain came on about 4.9M shares, which is average volume. The September washout days ran 13.3M and 21.4M. The MACD crossover is happening below zero, which is the lower-quality kind. Price is still under the 50 SMA at 57.23 and the 200 SMA at 61.51, the death cross is three and a half weeks old, and SuperTrend is down on all three tiers. The weekly and monthly z-scores sit around -0.95, so CARR is nowhere near statistically stretched on the downside. This isn't a spring-loaded, oversold name that bounces by reflex. There is room to fall.

The fundamentals are worse than the chart. Q1 2026 revenue grew 2.4% while operating income fell 59%, from 629M to 259M. Operating margin went from 12.1% to 4.8%, the lowest operating income in the whole series, below even the Q1 2020 COVID quarter. If you say Q1 is seasonally weak, I agree, but the comparison is Q1 against Q1, and the seasonality is already in the base. Free cash flow was about negative 15M against positive 420M a year earlier. Cash has gone from 3.97B to 1.37B. By the report's own derivation, the dividend eats roughly 90% of TTM FCF. The 17x forward P/E rests on EPS going from $1.38 trailing to $3.31, and I know those two aren't like-for-like, but the Q3 print has to bridge that gap with a margin snapback nobody has shown me yet.

On supply, Viessmann sold about $1.05B of stock over the last year, at $62.01 and $70.30, both well above today's price. The CEO's purchase was about $1.0M at $52.62. That's roughly a thousand to one, and the purchase is eleven months old.

Now the sell-side objection, which the neutral analyst will probably raise: five targets average about $64.4, roughly 14% above the price. But every action in the window was a cut or a downgrade, with no raises. Stephens at $55 is below the current price, and Goldman's $61 comes with a Neutral rating, which isn't a conviction call. Targets are lagging price, not leading it. I hold the rotation story loosely, since it comes from one StockTwits post relaying a headline that Goldman upgraded Trane while downgrading Carrier. But it fits the pattern.

Here's the math from the plan's own numbers. A clean print stalls at $61 to $64, about +10% from 56.6 at the midpoint. A miss gaps to $48 to $50, about -14%. To break even on a full-size position you need better than 57% confidence in the clean outcome. With four target cuts, a downgrade, a Q1 margin collapse and no Q2 read, that conviction hasn't been earned.

Neutral analyst, you'll point to ATR contracting to 1.38, narrow Bollinger bands and a five-week range. If CARR is range-bound, you sell the top of the range, and 56.5 is the top. Volatility contraction ahead of a binary event isn't safety. It's the quiet before the gap. The ATR is about 2.5% a day, and the event is worth five or six of those. The tools don't say what caused the July 28-29 drop from 69.33 to 59.92, about 13.6% in two sessions on roughly 16M shares each day, but it's the same size as the 14% scenario. Range statistics describe a regime that's about to end.

You may also say the 50 SMA is falling toward price, so a reclaim gets easier. That's true, but it's mechanical, and I won't treat a falling average as a signal. The real test is the daily SuperTrend flip at 58.47, and the plan names it as the invalidation. A close above it with a clean Q2 read, and I change my mind. You may say the bar is lower and a beat could squeeze. That's the best bull argument, and it's why we keep half. I'm not predicting a miss. I'm declining to carry full size into a negatively skewed setup. And "wait for the print" isn't a strategy, because the print is the gap and you can't trade it at today's price.

To the conservative analyst, if you want zero: a full exit at the top of a bounce forfeits exactly the squeeze scenario above. The residual is a deliberate bet with a hard line, a heavy-volume daily close below 52.96. I'd add that the stop handles drift, but it does nothing for an overnight gap, so the residual has to be sized to survive a drop to about $48. And if you say missing data means we shouldn't act, that's backwards. The Q2 filing, the confirmed earnings date and the options-implied move are all missing, and that argues for smaller size, not for standing still. They're to-do items before the print. If the implied move comes in well under 14%, I'll listen to the neutral case more. If it's bigger, I'd trim further.

I'm leaning lightly on a few things. The 10-21 bar is a partial session, sentiment rests on three unlabeled StockTwits posts with Reddit off, and the macro pull failed, so I have no real rate readings.

If you hold CARR, trim to about half of a standard allocation into 56.4 to 56.8 and don't sell into weakness near 53 to 54. Exit the rest on a heavy-volume daily close below 52.96. If you're flat, stay flat and place no pre-print buy orders. Restore weight only after a daily close above 58.47 with a clean Q2 read, or after a clean Q3 print.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Before I defend anything, I owe you some corrections, because you're both right on several points.

Neutral, you're right about Viessmann. The $300M block at 70.30 was June 2025, so only the $750M sale at 62.01 is inside the last twelve months. My thousand-to-one comparison with the CEO's purchase is really closer to seven hundred to one. The stock also ran from 62 to 75.73 in the five weeks after that sale, so another block is a tail risk, not a ceiling. I'm dropping it as a pillar. Conservative, you're right on cash. It has sat between 1.37B and 1.56B across three balance sheets, so the drain is old news. Current liabilities were also 8.6B in March 2024, so I can't call the Q1 jump a warning. You're both right on the heavy-volume filter too. An exit that's harder to trigger is backwards, so it's a plain close below 52.96, and that's a trend-failure line, not gap protection. Neutral, you're also right that a z-score near minus one says there's no oversold spring, not that there's room to fall. I only needed the first half of that.

Here is what still stands.

On the bounce, the OBV rise of 24M since 10-14 looks like participation, but the same report notes that OBV on 10-14 was lower than on the September capitulation day even though price was higher. That reads as distribution in early October. The 24M mostly refills that hole. OBV is about 5M better than on 09-21, a month ago, and today's bar is partial. I'd call that a rebound that has repaired itself, not one that has built anything. "The market shrugged off the cuts" overstates it too. Price is back at the top of a five-week range, where it stalled at 56.79 on 09-25. That's a round trip inside a range, not a verdict on the thesis.

On skew, I accept the arithmetic. Move the inputs and the hurdle slides toward 50%, so I'll stop calling it negatively skewed. It's a coin flip with fat tails. But that is the case for the plan as written. Nobody here is recommending zero. I won't carry full size into a coin flip with a 14% hole under it. I will carry half.

On half versus a quarter, Neutral already did the math. At a coin flip, the second quarter is worth roughly half a percent of the original position. Conservative, that's too thin to justify "finish by date at any price," and the cost lands in the scenario you call recoverable. If a clean print gaps to 62, you don't re-enter near 56.6. You pay through the gap. But your loss-budget formula settles this better than either of us can. Maximum residual weight equals the loss you can tolerate divided by the larger of 14% and the implied move. If half a standard allocation fits under that, keep half. If it doesn't, the formula wins. That makes half versus a quarter a function of the holder's risk budget, not my taste or yours. The plan already said to reduce further if the residual can't absorb a 14% gap, and your formula makes that concrete, so I'll adopt it. I'll take Neutral's calendar version too. Whatever sits above the ceiling goes by the close two sessions before the print, at whatever price. The discretionary half stays price-driven.

I won't follow Conservative on "default to the smaller size if the implied move is unknown." The implied move is a quick lookup on the options chain, and the earnings date is in an advisory that's already out. Treating missing data as bad news is pessimism dressed up as a rule. If you truly can't get the number, the 14% floor is already the cautious assumption, and the formula uses it. The July drop deserves one more note. It was 13.6% in two sessions on about 16M shares a day, and we all suspect it was the Q2 print. If so, it's the best evidence that this stock reprices around 14% on earnings. Whatever management said in July is also the bar Q3 gets judged against, so read that release before the print.

On "don't sell into weakness," Conservative says it commits you to doing nothing. It commits you to something specific. If CARR fades to 53 or 54, you cut only what the ceiling requires and hold the rest to a close below 52.96. Neutral's math shows why. From 54 the upside is about 16% against about 9% down, and breakeven odds fall to the high thirties. Selling there gives away the best part of the skew. 56.4 to 56.8 is where the skew is worst, so that's where I sell. I like Neutral's layering, roughly a quarter now and a quarter into the 50 SMA area at 57.2 to 57.5 if it gets there. I wouldn't be precious about twenty cents. Today's high of 56.62 is already inside the zone.

Neutral, on re-entry, the plan already says a daily close above 58.47 with a clean Q2 read, or a clean Q3 print. So 58.47 isn't the only door back in.

On options, I have no data, so this is conditional. If the chain prices the move sensibly, a put spread below 53 on the residual is the only tool that actually addresses overnight gap risk, and it would let someone keep more than a quarter. If the chain is pricing something near or above 14%, don't pay up. Let the ceiling do the work.

So for anyone holding CARR, sell roughly a quarter of a standard allocation now into 56.3 to 56.8. Sell a second quarter into 57.2 to 57.5 if price gets there, but never carry more into the print than the loss-budget ceiling allows. Exit the rest on a plain daily close below 52.96. If you're flat, stay flat and place no pre-print buy orders. Rebuild only after a daily close above 58.47 with a clean Q2 read, or after a clean Q3 print.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We've converged on most of it, so I'll concede what's earned and fight for what's left.

Neutral, you're right on July. Closes went from 69.33 to 63.16, down 8.9%, then to 59.92, down another 5.1%. That is 13.6% over two sessions, not one gap, and we're all guessing it was the print. I called it the best evidence for a 14% earnings reprice, and it isn't. Fourteen is a stress number, and the precedent is closer to nine on day one. That helps the keep-half case. A half position takes about 4.5 points of the original on a nine, against 7 on a fourteen.

Conservative, your Q1 point is the best new argument in the thread. The margin collapse was public before the June 25 peak, and the stock still ran more than 20% from the May sale at 62.01 to 75.73. So I can't treat Q1 operating income as news. But it points somewhere. Whatever drove the 29% slide happened after Q1, probably in the Q2 release and call, and Bernstein, Stephens, RBC and Mizuho cut after that. My fundamental case is now thinner. What's left is the trend, the event, and the direction of estimate revisions. The Q2 release is the keystone, and reading it tonight is step one for anyone holding this.

Now the real disagreement. Conservative, you say the extra quarter is worth about minus half a point at a coin flip, so the tail should break the tie. I agree the edge is tiny, and that is my objection to a blanket rule. If the edge is within noise, the tiebreaker should be the one thing we can actually measure, the holder's loss budget. Neutral's arithmetic shows it. A half-percent budget against a 14% gap allows about a 3.5% weight, so half of a standard allocation fits unless the standard is above about 7% of the book. Your quarter is right for the concentrated holder and wrong for the diversified one. I'll give you a fallback: if someone can't state a loss budget, or won't do the lookups before two sessions out, carry a quarter. That's a reasonable default for someone who hasn't done the work, but it shouldn't override the formula for someone who has.

On missing data, you're right that the lookup can only shrink the ceiling, and I won't pretend 14% is a cap. But a one-sided input doesn't justify a default when the lookup is an evening's work. Neutral's version improves it. With the denominator at the larger of 14% and about twice the implied move, the lookup is live exactly when it should be, which is when the chain prices roughly 7% or more. That's a rule of thumb, not data, and I have no options data. Below that, the 14% floor already covers you. Above it, you shrink. I'll take that.

On weakness, you're right that 54 and 52.96 sit under 2% apart. If the stock fades into the print, don't be precious. If you're over your ceiling, sell at 54. If you're at or under it, the stop is the stop. And you're right that the better skew from 54 only holds if the miss is a level, not a percentage. I wouldn't lean on it.

Neutral, I'll take your calendar on the second tranche. The 50 SMA is dropping roughly a dime a day, because mid-August closes of 61 to 63 are rolling out, so my 57.2 to 57.5 limit could wait on a level the average itself moves under. Work the second quarter around 56.7 to 57.0 for a couple of sessions, and whatever isn't done by the close two sessions before the print gets sold down to the ceiling at market.

I'll go further on re-entry. You said a miss that gaps to 49 with a release showing margins at a trough could be the best entry in this thread. I agree, and I think that's the bold part of the plan. The trim isn't a retreat. It creates the cash to buy 48 to 50, which is below the CEO's $52.62 and near the November low, if the Q2 and Q3 read says the margin damage is a trough and not a trend. It's also why I won't sell more than the ceiling requires. The residual is a deliberate position with a line at 52.96, and it keeps the squeeze if a clean print gaps to 61 to 64. That is capped by the 200 SMA at 61.51 and Goldman's $61, so I'm not pretending it's a big prize.

One pushback, Neutral. You say this is risk management, not a bearish thesis, and I accept that. But "not a thesis" can't slide into holding full size. All three SuperTrend tiers are down, the death cross is three and a half weeks old, price is under both averages, and every sell-side action in the window was a cut. That's enough to say don't carry full weight into the event, even though it isn't enough to say the stock goes to 48.

So for anyone holding CARR: sell the first quarter of a standard allocation now. Today's 55.83 to 56.62 range already covers it, and the bar is partial, so don't wait for 56.8. Tonight, read the Q2 release and 10-Q, confirm the earnings date, and pull the implied move. Set your ceiling at your tolerable gap loss divided by the larger of 14% and about twice the implied move, and carry the lesser of half and that ceiling into the print. Use a plain close below 52.96 as a trend-failure line, not gap protection. If the print gaps through it, read the release before dumping the rest. A put spread below 53 is a way to carry more, but only if the chain prices it sensibly. Re-enter on information in either direction: a close above 58.47, or a release showing margins have troughed. If you're flat, stay flat into the print.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We're down to a handful of real disagreements, so let me take what's earned first.

Conservative, your fourth point lands. I said targets lag price, then leaned on the run of cuts as if it were a forecast. I can't have both, so I'm dropping revision direction as a bearish pillar. Neutral, your point goes with it: three SuperTrend tiers, two averages and a death cross are one fact, a 29% fall, counted five ways. What's left is a trend nobody has challenged (the weekly stop is still 16% overhead at 66.98), an event we can't size, and a position that may be too big for it. That's a sizing case, not a call on direction. I'd say it's the strongest form of the case, because it doesn't need me to be right about 48 or 64.

It's also why I'm not at zero. Neutral, you're right that "nobody is recommending zero" was an argument from the seating chart. The real reason is in the data. Q3 2025 was already soft, with revenue down 6.8% and operating income down 29% to 539 million, a 9.7% margin. That's a softer comparison than the 12.1% Q1 had to clear, and the cuts have reset expectations. Both are inferences, not facts, but they make a clean print plausible. That's a reason to keep a residual. It isn't a reason to keep full size.

On size, Conservative, I accept that half is a ceiling, not a headline. Neutral, I accept that a fixed quarter is a number dressed up as a test. Going from half to a quarter cuts gap exposure by about 3.5 points of the original position and costs about half a point of expected value at a coin flip. That's a good trade for a concentrated holder and a poor one for someone whose half already fits their budget. So the rule is the test: pre-print position times 14%, or twice the implied move if that's larger, against what you'd tolerate losing on one name overnight. The quarter fallback I offered last round stays for one person only, the one who won't do that sum by two sessions before the print. That person isn't sizing, they're hoping, and small is the right default for hoping.

On July, we all agree we only have closes. Neutral's nine and my fourteen are both stress numbers, not precedents, and the rule already uses 14 as the minimum denominator plus twice the implied move. But Conservative, take the other half of your own observation. The stock closed at 59.92 on 07-29, was back at 61 to 63 by mid-August, and only then slid to 53.88. Gaps aren't the end of the story in either direction. That supports your bounded pause: if the print gaps through 52.96, read the release before the open and decide by that day's close.

On buying a gap, I'll take your staging. Nothing on day one. A small starter on day two or three, after the call and some price action. Bigger adds come only on a reclaim of 52.96 or a read that meets a definition. Neutral, you asked me to define "trough" before I need it. Mine is that the year-over-year operating margin shortfall narrows from the 7.3 points Q1 showed (12.1% down to 4.8%) and full-year guidance isn't cut again. "Less bad than feared" doesn't count. Conservative, you're right that one release shows deterioration more easily than a trough. That's why the cash is an option, not an obligation. If the release shows margins still sliding, you buy nothing, and the trim has already paid for itself. If it shows a trough, you have dry powder at 48 to 50. And the reports themselves disagree on the low, 49.79 on closes versus 50.24 on the 52-week range, so that's a support zone, not a line.

Both of you keep drifting toward the version where caution is free. It isn't. "Wait for the print" means owning the gap at full size, and "go to a quarter by default" sells three quarters of a position on an edge you computed at half a point. The bold version is the one on the table: act before the event, keep a defined residual, and hold cash to buy the outcome that actually pays.

So for anyone holding CARR, sell the first quarter of a standard allocation now. Today's 55.83 to 56.62 range covers it, and the bar is partial, so don't hold out for 56.8. Tonight, read the Q2 release and the 10-Q, confirm the earnings date (if you can't, assume the earliest plausible one), and pull the implied move if you have an options chain. I have none. Run the test and set your ceiling. Carry the lesser of half and that ceiling into the print. Work the second tranche with a limit around 56.7 to 57.0 for a couple of sessions. The calendar enforces the ceiling: anything above it gets sold at market by the close two sessions before the print. Between half and the ceiling, price decides. If the stock has faded toward 54 and you're under the ceiling, the stop is the stop.

Treat the 50 SMA drifting into price as arithmetic. The real trend test is a daily close above 58.47. Exit the remainder on a plain close below 52.96, and call it what it is, a trend-failure line, not gap protection. A put spread below 53 is a fair way to carry more, but only if the chain prices it sensibly. If you're flat, stay flat into the print. Re-enter on information: a close above 58.47, or a read that meets the trough definition, scaled in stages.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Conservative, you've got me on the sign, and Neutral confirmed it, so I'll fix that first. On the plan's own payoffs, plus ten and minus fourteen, a coin flip is worth about minus two percent per unit held. Holding the extra quarter costs about half a point, and selling it earns that half point. I had it backwards. But look at what the corrected math says. On the plan's inputs the extra quarter is worth minus half a point. On Neutral's friendlier inputs it's worth plus a quarter to half a point, and change one input and it's roughly zero. An edge nobody can tell from zero can't decide between half and a quarter, so I'll stop pretending it does. The residual earns its place through optionality: the squeeze if a clean print gaps up, and the cash to buy if it gaps down. The cut earns its place through the tail. Neither is edge, so the holder's loss budget has to be the headline, not my taste for half or yours for a quarter.

On the second tranche, you're right that "price decides between half and the ceiling" was a hole. The diversified holder, the one half is supposed to fit, walks into the print at three quarters if the bounce fails and the limit never fills. That's the scenario we're trimming for. So I'll take Neutral's settlement. The ceiling is hard and on the calendar. Half gets a checkpoint at the same close, two sessions before the print. If you're above half, you sell to half or you write down why not, and the only acceptable reasons come from tonight's reading. I like that the exception runs both ways. A release showing margins still sliding puts the target under half. A release that isolates Q1 as a one-time hit, plus a small implied move, can justify carrying more, up to the cap. That's the bold part of this plan. The rules are fixed before the information arrives, and the information is allowed to move them.

I'm dropping the Q3 comp. Conservative, a comp is only soft against a run rate. Neutral, your table check settles the rest: in 2024 Q1 ran 7.1% against 12.8% in Q3, and in 2025 it was 12.1% against 9.7%, so seasonality points opposite ways. I'd add that our data doesn't agree with itself on the run rate. Q2 2025, Q3 2025 and Q1 2026 operating income add up to about $1.7B. The snapshot's 13.1% TTM operating margin on $22.1B of revenue implies about $2.9B. That would need a Q4 2025 near $1.2B, bigger than any quarter in our table. The report warned that the TTM figure may use a different definition, so calling 4.8% the run rate is as shaky as calling 9.7% a soft bar. The target cuts are already gone as a pillar, and the comp goes with them. The print is a two-way unknown, and the residual rests on optionality.

On the trough, Conservative is right. My year-over-year version could pass on a Q3 margin of 4.8%, because the comparison quarter is weaker. I'll take Neutral's written version: levels and sequence, GAAP and adjusted, Q1 explained with the one-time items itemized, and guidance at or above the last stated. I'd add that "above 4.8%" is a floor, not proof. A 5% margin with no itemized one-timers is a stabilization claim with no evidence behind it. You're also right that "not cut again" assumed a cut nobody verified, which is why the test is guidance at or above whatever was last given.

On re-entry, I think you're both right and the two views reconcile. Conservative, a buy after a gap is a new decision, and the trim's cash is neither an obligation nor permission. Neutral, the 14% in the denominator exists because of the event, and after the print it's gone. So it's the same loss budget with a different denominator, the distance to the new stop. Nothing on day one, a small starter on day two or three after the call and some price action, and bigger adds only on a reclaim of 52.96 or a read that meets the written definition.

On the put spread, I concede. A 53/48 spread covers the plan's stress case and leaves a gap to 46 uncovered, and protection bought into a known event is usually priced for it. I have no options data. It's a way to carry more than the cap, not a substitute for the cap.

Neutral, you said we've spent rounds on a quarter-point disagreement while the print may be days away. That's fair, and it's why I'd resist any version where the lookups are optional or later. Tonight is the work. And caution isn't free here. A plan that can only cut is just a conservative plan with extra steps, so this one has to say what it would buy and what would make it carry more.

Here's the plan in weights, with a standard allocation as one. Sell the first quarter of what you hold now, but never below your target. Today's range of 55.83 to 56.62 covers the zone and the bar is partial, so don't hold out for 56.8. Tonight, read the Q2 release and 10-Q, confirm the earnings date (if you can't, assume the earliest plausible one and work back), and pull the implied move if you have an options chain. I don't. Your cap is your tolerable one-night loss divided by the larger of 14% and about twice the implied move. Your target is the lesser of half and the cap, with a quarter for anyone who skips the sum. If you're already at or under target, there's nothing to sell. Work the second piece with a limit around 56.7 to 57.0 for a couple of sessions, and treat the falling 50 SMA meeting price as arithmetic, not news. By the close two sessions before the print, you're under the cap and at target unless tonight's reading earned a written exception. Exit the remainder on a plain close below 52.96. It's a trend-failure line, not gap protection. If the print gaps through it, read the release before the open and decide by that day's close. Re-enter in stages on information, either a daily close above 58.47 or a read that meets the written trough definition. If you're flat, stay flat into the print. Sell here means reduce, not short.

FINAL TRANSACTION PROPOSAL: SELL

Conservative Analyst¶

Conservative Analyst: Aggressive analyst, I agree with more of your read than you might expect. The chart is bearish, the fundamentals are worse, and you're right that a close-based stop does nothing against an overnight gap. But that last point is why I think the plan stops short.

You call a trim to half the bold move. I'd call it the middle of the road. Your breakeven math is right: with +10% on a clean print and -14% on a miss, you need roughly 57 to 58 percent confidence in the clean outcome just to break even. Then you say that confidence hasn't been earned. If so, the half you keep isn't a hedge against being wrong about the miss. It's a smaller version of a bet you've said has negative expectancy. It risks about 7% of the original position on the downside for about 5% on the upside. The squeeze argument doesn't rescue it, because the upside you describe stalls at 61 to 64. That's where the 200 SMA at 61.51, Goldman's $61 target and Viessmann's $62.01 block all sit. On the downside, the first marker below the September low is the November 2025 low around 50, and your miss case goes to 48 to 50, which is through it.

Now the stop. If the gap is the whole thesis, the 52.96 line isn't protection. Only the size of the residual controls that risk. The rule also says heavy-volume close, and heavy is never defined. A close below the September intraday low on ordinary volume wouldn't trigger it, so the filter makes the exit less likely to fire, which is the wrong direction for a risk control. Pair that with "don't sell into weakness near 53 to 54" and you've pre-committed to do nothing in the zone just before the event. I'd make the exit a plain close below 52.96 and stop describing it as a safeguard.

The trim itself also depends on the market cooperating. It fills only if the bounce keeps pushing into 56.4 to 56.8. If the bounce fails, which is the bearish case you're arguing for, the order doesn't fill and the weakness rule keeps you from chasing. You then walk into the print at full size. The Q3 date isn't confirmed, but Carrier has historically reported in late October, and the FOMC meets October 28 to 29, so there may be days, not weeks. I'd add a time backstop: if the trim isn't done two sessions before the print, sell at the market.

On missing data, you say it argues for smaller size, and I'd push that further. The Q2 filing, the confirmed date and the implied move aren't to-do items, they're inputs to sizing. Your plan says to size for the larger of 14% or the implied move, and nobody knows the implied move. Until we do, the residual is unsized. Here's a rule anyone can apply to their own book. Take the loss you can tolerate on this name from a gap, divide by the larger of 14% and the implied move, and that's your maximum residual weight. A half-percent loss budget gives about 3.5% of the portfolio, whatever "half a standard allocation" happens to be.

The July 28-29 drop matters here too. It was 13.6% in two sessions on about 16M shares a day, and the tools can't say why. My guess is the Q2 print, since Carrier usually reports in late July, but that's my inference, not tool output. Either way, a move the size of your miss case has already happened to this stock. The one filing that might explain both July and the Q1 margin collapse is the one we don't have.

Since the neutral analyst hasn't spoken, let me address the likely points. The five-week range and the 1.38 ATR describe five weeks with no earnings print in them, so they can't size the print. "The bar is lower" is plausible, but nothing in our data shows consensus estimates, and the news says only that the cuts could lower the bar or signal a guidance cut. The 17x forward multiple rests on $3.31 against $1.38 trailing and recent quarters of 28 to 50 cents. If that forward number were trimmed 20%, which is my illustration, the multiple becomes about 21x. The CEO's roughly $1M purchase at 52.62 came in November 2025, before the Q1 operating income collapse was reported, and it's about a thousandth of what Viessmann sold. On rates, FRED failed, so we have no readings. The thin prediction markets show no cuts priced for 2026, a 12% chance of an October hike and a high chance of another hike by December. That's a rate-sensitive end market facing a possible hike inside the same window as the print.

One correction in the interest of accuracy. Cash fell from $3.97B at the end of 2024, but it has sat between about $1.37B and $1.56B across the last three balance sheets, so the drain isn't new. What worries me more is that current liabilities jumped from about $7.1B to $8.6B in Q1, the current ratio is about 1.05, and we don't know why. Add a dividend near 90% of TTM FCF (a derived figure) and Q1 free cash flow slightly negative, and the cushion is thin heading into a guidance event.

So my adjustment is to go lower than half. For a holder, I'd cut toward a quarter of a standard allocation, or whatever the loss-budget formula allows, whichever is smaller, and finish by a set date before the print, not by a price. If the implied move isn't known when the decision comes, default to the smaller size. Make the exit a plain close below 52.96, and treat size, or defined-risk protection if the options market prices it sensibly (I have no options data), as the only real gap protection. If you're flat, stay flat and buy nothing pre-print. After the print, rebuild in stages, starting only after a daily close above 58.47.

I'll own the cost. On a clean print that gaps to 61 to 64, the portion I sold misses about 10%. But that cost is bounded and recoverable, since re-entry after a confirmed flip is still available. A 14% gap through a stop that can't fire is neither. I'd soften this only if the implied move comes in well under 14% and the Q2 filing shows Q1's margin collapse was one-time.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: I'll start by giving back what I got wrong, because it narrows the argument. Neutral is right that only the $750M Viessmann sale is inside the last twelve months, and that 62.01 isn't resistance after the stock spent two months above it. I also concede the cash drain is old news, that current liabilities were 8.6B in March 2024, and that the rate-hike numbers are too ambiguous to lean on. The 86% hold on deep volume is the only solid macro number. I'm also fine with a plain close below 52.96, called a trend-failure line and not gap protection. What's left of my case is smaller, but it's the part that matters.

Neutral, your own arithmetic is my argument. You said the second quarter is worth roughly half a percent of the original position in expected value at a coin flip. I agree. On the plan's payoffs of +10% and -14%, each unit held has an expected value of about -2%, so half a position costs about a point of expected value and a quarter costs half a point. Under your friendlier inputs it's roughly zero. Either way, we're paid close to nothing for carrying that extra quarter. In exchange it puts about 7 points of the original position at risk in a miss, against 3.5 for a quarter. When the expected edge is about zero and the tail is a gap, the tiebreaker should be the tail.

Aggressive, you say the 14% floor is already the cautious assumption. It's the most permissive input we could use. Under your own formula, the denominator is the larger of 14% and the implied move, so the ceiling can never exceed the loss budget divided by 14%. Looking up the implied move can only shrink what you carry, never grow it. So the missing number isn't neutral, it's one-sided, and defaulting low until you've seen it isn't pessimism. It's the same sizing rule with the one input we can't see set to its worst case. Also, 14% is the plan's own miss scenario, not a bound. The July drop, 13.6% in two sessions on about 16M shares each day, shows the stock can do that. And we all guessed it was the Q2 print without evidence.

There's also something none of us has pointed out. The Q1 margin collapse was public long before the June 25 peak of 75.73, and the stock climbed more than 20% from the May block sale at 62.01. So the market already looked at Q1 and bid the stock up. That weakens the Q1 margin pillar. It also means the datum that mattered was probably the Q2 report and call, which are exactly what we haven't read. We'd be sizing a position through the next print without having read what caused the last big move. That is the reason for caution.

On not selling into weakness, I see two problems. First, the stop is 52.96 and the weakness zone is 53 to 54, so the gap is under 2%. A rule that refuses to sell at 54 and then sells on a close below 52.96 doesn't preserve the skew. It means selling the next day, below the September low, which is the worst place to sell. Second, price and probability aren't independent. If the stock fades through the 10 EMA at 55.50, the Bollinger middle at 55.41 and the lower band at 54.28, that's evidence the bounce is failing and the miss is more likely. So the breakeven odds fall to the high thirties, but the odds of a clean print fall too. Neutral admitted the improved skew only holds if the miss is a level. If it's a percentage gap like July's, 14% from 54 is about 46.

On execution, I accept that the first piece isn't hostage, since today's 56.62 high is already in the zone. The second piece at 57.2 to 57.5 is different. It needs a move through the 50 SMA that the stock hasn't made since September. If it doesn't fill, you're at three quarters going into the print, and the only thing between you and that is a ceiling nobody has computed. I'd set the second piece by the calendar and the three lookups, not by a resting limit order.

On re-entry, Neutral says paying up through a gap to 62 is a real cost. It is, but it's bounded and known: about 2.5 points of the original position on a quarter, and you still own the rest. A 62 gap also lands just above the 200 SMA at 61.51, where supply is, so it isn't a free run. After a gap down there's no price at which you could have gotten out.

So here is what I'm asking for, and it's narrow. Sell the first quarter now into the 56.4 to 56.8 zone, or at the market if the bounce fades. Before the second decision, do the three lookups: read the Q2 release and 10-Q, confirm the earnings date, and pull the implied move. Divide your tolerable gap loss by the larger of 14% and the implied move, and that is your cap. I can't see anyone's standard allocation, so I can't tell you whether half fits under it. If you haven't done the math or can't get the inputs by two sessions before the print, the default is a quarter, not half. You can add back after the read, but you can't undo a gap. A put spread below 53 is a legitimate way to carry more, but only if the price is sensible. If you're flat, stay flat, and rebuild in stages after a post-print read that margins are stabilizing, or after a close above 58.47.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We've converged further than the transcript makes it look, so I'll start with what I'm taking.

Sell the first quarter now, since today's 55.83 to 56.62 range already covers it. Use a plain close below 52.96 and call it a trend-failure line. Put the second tranche on a calendar, not a resting limit. Neutral's point about the 50 SMA is right, and it cuts further than anyone has said. At roughly a dime a day it will be near the top of the current range within a few sessions, so "reclaiming" it becomes nearly automatic and tells us nothing. The only trend test that matters is the 58.47 daily flip. I also accept Neutral's doubling of the implied move. Under "larger of 14% and the implied move" the lookup almost never binds, so doubling makes it a live input. It's a rule of thumb, not data, but it's better than a ceremonial step. And Aggressive's fallback, a quarter for anyone who can't state a loss budget or hasn't done the lookups two sessions out, is what I was asking for.

Here is where I still see soft spots.

First, the cap everyone now leans on. The half-percent loss budget, the 3.5% ceiling and "half fits unless your standard allocation is above 7% of the book" all trace back to my illustration. I don't know anyone's actual budget, and neither do you. The logic is right that a quarter suits the concentrated holder and half the diversified one. But the formula's output is the holder's own number, so half is a ceiling, not a recommendation. I'd write the plan that way, with a quarter as the default for anyone who hasn't computed it, and not leave "half" as the headline.

Second, July. Neutral, you called the overnight gap about nine percent. What we have is 69.33 to 63.16 on closes, which is the close-to-close move, not the opening gap. The gap could be smaller or larger, and we still don't know the print caused it. So I wouldn't treat nine as the earnings precedent, any more than Aggressive should treat fourteen as one. What we do know is that the stock lost 13.6% in two sessions on about 16 million shares a day. The second leg, the one a holder could "act on," came on 16.6 million shares, which is not a quiet tape. That's why I keep 14% as the sizing floor. It isn't a base case, but it's the only earnings-sized move in the data, and its cause is unexplained.

Third, buying the gap. Aggressive, I see the appeal, and Neutral endorsed it. But a gap to 48 to 50 means price has gone through the 52.96 line we just called trend failure, and it's at or below the November low. The reports disagree on that low, 49.79 on closes in the technical report and 50.24 in the fundamentals snapshot's 52-week range. Either way, 48 to 50 is at or through it. That's buying after support has failed, on the strength of one release that supposedly shows margins have troughed. Q1 operating margin was 4.8% against 12.1% a year earlier. One release can show margins got worse far more easily than it can show a trough. I'm not against re-entering after bad news. I'm against doing it on day one, off the same release that just broke your line. Start small, wait for the call and a session or two of price action, and treat reclaiming 52.96 as a better first add than 49.

The same goes for "read the release before dumping the rest." July cuts both ways. The stock closed at 59.92 on 07-29, then traded back to 61 to 63 by mid-August, so a seller at the low would have regretted it. But it then slid to 53.88 by 09-18. So I'd bound the pause: if the print gaps through 52.96, read the release before the open or in the first session, and decide by that day's close. An open-ended "wait and see" turns the one hard rule into a discretionary one.

Fourth, something I don't think anyone has said plainly. This case never needed a view on direction. Aggressive keeps citing three SuperTrend tiers down, a death cross and a run of target cuts. But earlier he said targets lag price, and now he uses the direction of revisions as a pillar. He can't have it both ways. The death cross is a lagging signal, the 50 SMA is falling mechanically, and Q1's margin collapse was public before the June peak. After everything we've given back, the honest bear evidence is a broken trend and an event we can't price. That doesn't say the stock goes to 48. It does say the position is oversized for a risk we can't measure. That is a sizing argument, and it's why I don't want half to become the default.

The practical version is short. Tonight, read the Q2 release and the 10-Q, confirm the earnings date, and pull the implied move. The advisory is already out, so the date should take minutes to find. If you can't confirm it, assume the earliest plausible one and work your deadline back from that. Carry the lesser of half a standard allocation and your formula ceiling, and a quarter if you haven't computed it. A put spread below 53 is a fair way to carry more, but only if the chain prices it sensibly. I have no options data. If you're flat, stay flat into the print.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We've converged enough that I'll skip a recap and take what's earned. Sell the first quarter now, since today's range already covers it. Make the exit a plain close below 52.96 and call it a trend-failure line. Put the second tranche on a calendar. Write the size rule as a test, with a quarter for anyone who won't do the sum. Aggressive, dropping revision direction as a pillar was the right call. Neutral, your point that the death cross, the averages and the SuperTrend tiers are one 29% fall counted five ways is exactly right. What's left is a sizing case, so let me press on the sizing.

Aggressive, I think the sign is off on your expected-value claim. You said going from half to a quarter costs about half a point at a coin flip. On the plan's own payoffs, plus ten and minus fourteen, a coin flip is worth about minus two percent per unit held. The extra quarter is the piece that costs half a point, and selling it earns that back. Only on Neutral's friendlier inputs does holding it come out ahead, and then by about a quarter point. So the edge on that quarter sits somewhere between minus half a point and plus a quarter point, and nobody knows where. The extra 3.5 points of gap exposure doesn't depend on any assumption. That's a close call on edge against a fixed tail, not selling three quarters of a position on a computed edge.

The second quarter is still unenforced, and that's the bigger hole. Both of your plans say to carry the lesser of half and the ceiling. But the calendar only forces you down to the ceiling, and Aggressive explicitly says that between half and the ceiling, price decides. For the diversified holder, the one everyone says half fits, the second quarter sells only if the stock reaches 56.7 to 57.0. If the bounce fails, which is the case we're trimming for, it doesn't fill. The stock sits at 54, the rule says the stop is the stop, and they walk into the print at three quarters. That's the fill problem I raised in round one, moved to the second tranche. A firm first quarter and a discretionary second is a fine plan if we call it that. But then half is an aspiration, not the plan. I'd put the move to half on the calendar too, and let tonight's reading of the Q2 release and the 10-Q earn any exception.

Aggressive, your Q3 2025 argument is also thinner than it sounds. You said the 9.7% margin is a softer comp than the 12.1% Q1 had to clear, which makes a clean print plausible. A comp is only soft relative to a run-rate, and the run-rate we can see is 4.8%. Q1 2026 operating income of 259 million would have to roughly double just to match the quarter you call soft. Seasonality in our own table doesn't rescue it, because in 2025 Q3 margin came in below Q1. You also dropped the target cuts as a bearish forecast because targets lag price. By the same logic they mostly reflect the 29% drop, not fresh information on estimates, and we have no consensus numbers. The sentiment report says the cuts could lower the bar or signal a guidance cut. You flagged these as inferences, which is honest, but you're still using them to justify the size of the residual.

That leads to your trough definition, which I'd tighten before anyone relies on it. A year-over-year margin shortfall that narrows from 7.3 points can narrow purely because the comparison quarter is weaker. A Q3 margin of 4.8%, no better than Q1, would show a 4.9-point shortfall and pass. Define it in levels and sequentially, with guidance intact. Read it on adjusted figures too, since the market has probably been looking at those and we haven't. "Not cut again" also presumes a cut we haven't verified.

On buying the gap, I can live with a small starter on day two or three. But the plan sells the residual on a close below 52.96 and then buys back lower, so the buy has to be a new decision with its own cap. Total exposure after the starter should stay inside the same overnight loss budget. If the release shows margins sliding or guidance cut, the trim's cash is not an obligation, and it isn't permission either.

Two smaller points. Aggressive says to sell a quarter of a standard allocation, and Neutral says a quarter of your position. We don't know anyone's holdings. Define a target weight, the lesser of half a standard allocation and your ceiling. If you're already at or below it, there's nothing to sell. And the earnings date is unconfirmed, so two sessions before could be this week. The lookups are tonight's job, not something for later.

On the put spread, it only protects between its strikes. A long put near 53 and a short put near 48 leaves a gap to 46 uncovered, and protection bought into a known event is usually priced for it. That's general knowledge, not our data, and I have no options chain. It's an option for someone carrying more than the ceiling, not a substitute for it.

So my version is simple. Sell the first quarter now. Do the lookups tonight. Set a target weight, with a quarter if you haven't computed it. Use the calendar to enforce that target, not just the ceiling. Exit on a plain close below 52.96, and cap any re-entry inside the same loss budget. If you're flat, stay flat into the print.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We've converged enough that I'll say what I'm taking and where I still won't sign off.

I'm taking the calendar-enforced cap, the half checkpoint at the same close, the written trough test in levels and sequence, and the sign fix on expected value. Neutral, you're also right that the 14% belongs in the pre-print sizing and not in the post-print sizing.

Aggressive, you now say the residual earns its place through optionality: the squeeze on a clean print, and cash to buy a gap down. Those two pull in opposite directions. The cash to buy 48 to 50 comes from what you sold, so a bigger residual means less dry powder, not more. The squeeze is capped by your own numbers at 61 to 64, with the 200 SMA at 61.51 and Goldman's $61 sitting right there. Going from a quarter to a half adds about 2.5 points in the clean case and costs about 3.5 in the miss case. That's the same coin flip with a bigger bill on one side. Half should stay a ceiling and not be argued as a virtue.

On the exceptions, you both now allow carrying more than half if tonight's reading earns a written exception, with a Q2 release showing Q1 as a one-time hit, or a small implied move, as examples. I'd tighten that, for three reasons. - Rules fixed before the information arrives only mean something if the exception meets the same bar as the trough test you just wrote. A release that calls Q1 one-time doesn't show margins above 4.8% in levels, GAAP and adjusted, with guidance intact. It also looks backward, while the print is Q3. - A small implied move shouldn't count again, because the cap already uses it. - If the July 13.6% drop was the Q2 print, which is my inference and not in the tools, then the market's own reaction to that document was a sale. The exception would lean on the one document with indirect evidence that it disappointed.

So carrying less than half needs no justification, and carrying more needs the full written test.

On the first sale, you both say to sell a quarter of what you hold now. The cap is a percent of the book and the target is a fraction of a standard allocation, so convert the cap into standard-allocation terms before taking the lesser. And look at what a quarter does to an overweight holder. Someone at twice a standard allocation sells a quarter, ends at one and a half, and leaves everything else waiting for a deadline. The only reason to wait is a better price. We all agree the top of a five-week range, under the 50 SMA, ahead of a binary event, is the worst place to be long. So the quarter is a floor, not the size. Tomorrow, once the sum is done, sell whatever sits above the cap at the first opportunity, not at a resting limit.

The runway may also be shorter than it sounds. Today is Wednesday, the date is unconfirmed, and Carrier has historically reported Q3 in late October. If it lands early next week, two sessions before could be Friday's close. "Work a limit for a couple of sessions, then sell at market" could be the entire window, so the limit at 56.7 to 57.0 is a courtesy and not a plan. Work back from the earliest plausible date.

Neutral, on re-entry I agree the event is behind you after the print, but sizing a starter to the distance to the new stop has a trap. Put a tight stop under a fresh gap low and a fixed loss budget lets you buy something large. The post-print tape is the least reliable one. July gave up another 5.1% on day two, on 16.6M shares. So size from the post-print ATR, which will be wider than today's 1.38, and put a hard cap on the starter, no bigger than the quarter fallback until the stock closes back above 52.96. Otherwise the buy-the-gap leg becomes the riskiest part of the plan with the loosest rule.

Aggressive, you said caution isn't free, and I agree. The cost of the extra quarter sold is bounded, known and about half a point at a coin flip. The cost on the other side isn't bounded by anything we can see.

So here's my version. Sell at least a quarter now, then everything above your cap as soon as you've done the sum. Be at half by the checkpoint, and above half only by passing the full trough test in writing. Treat a plain close below 52.96 as a trend-failure line, not gap protection. After a gap, wait for the call and some price action, then start small with a hard cap. If you're flat, stay flat into the print. Sell here means reduce, not short.

FINAL TRANSACTION PROPOSAL: SELL

Neutral Analyst¶

Neutral Analyst: Let me start with what you two share, because it narrows the argument. You both want to sell this bounce, you both treat the daily SuperTrend flip at 58.47 as the level that changes the story, and you both flag the missing Q2 filing, earnings date and implied move. The real fight is half versus a quarter. I think each of you leans on some weaker supports than you admit.

Aggressive analyst, the z-scores first. Weekly and monthly readings near minus one say CARR isn't stretched. They don't say there's room to fall. A stock that has dropped 29% has dragged its own average down with it, so it reads as unremarkable. That's the absence of a mean-reversion signal, not a bearish one. The bounce volume is similar. Yes, 4.9M on the 20^th is average, but OBV has climbed about 24M since the 10-14 low, so the rebound has some participation behind it. Your supply point also needs a correction. The fundamentals report says Viessmann sold $1.05B in the past twelve months, but the $300M block at 70.30 was June 2025, sixteen months ago. Only the $750M sale at 62.01 in May is inside the year, and the stock then rallied to 75.73 within five weeks. Another block is a tail risk, not evidence of a ceiling.

Your breakeven math is also more fragile than it sounds. The 57% hurdle comes from the downside divided by upside plus downside, and both numbers are the plan's own picks. Let a clean print run to 64 or 65 instead of stalling, and the hurdle drops to about 50%. Make a miss 10% instead of 14%, since a 13.6% July drop, four target cuts and a downgrade have already reset expectations, and it's also about 50%. So this is closer to a coin flip with fat tails on both sides. That argues for a haircut in size, not for calling the setup negatively skewed. The stock also closed at 54.24 on the Goldman downgrade day and is 3.7% higher since, so the market has so far shrugged off the cuts.

Conservative analyst, you say the half we keep is a smaller version of a bet with negative expectancy. Nobody established that. The claim was that 57% confidence hasn't been earned, which means we don't know. Your quarter-size plan also rests on the same two-point payoff. Going from half to a quarter sells another quarter of the position. At a coin flip that's worth roughly half a percent of the original position in expected value, and about one percent if you think clean odds are only 40%. That's real but small, and smaller than the damage bad execution can do. "Bounded and recoverable" also undersells the cost. If the print is clean and gaps to 62, you aren't re-entering near 56.6. You're paying up through the gap.

Some of your supports are weaker than they sound. Viessmann's 62.01 isn't resistance, because the stock spent two months above it. The 200 SMA at 61.51 is a legitimate hurdle, but a past sale price isn't. On rates, you cite a 12% October hike chance, but the same report says it fell 18 points in a week, hold is 86% on deep volume, and recession odds are 8%. The report also warned against reading the thin hike-count markets as additional hikes from here. The jump in current liabilities from 7.1B to 8.6B has a precedent too, since the balance sheet was at 8.6B in March 2024. It could be seasonal or a debt reclassification. We can't tell, so I wouldn't make it a pillar. And on fill risk, today's high of 56.62 is already inside the 56.4 to 56.8 zone, so the first piece of the trim isn't hostage to a further push.

You each get something right. Conservative is right that the heavy-volume filter is a hole, and a close below 52.96 should simply be a close below 52.96. The loss-budget formula is also useful. Aggressive is right that gap risk is a sizing problem, and that "don't sell into weakness" is more coherent than it's given credit for. With the plan's own payoffs, selling at 54 instead of 56.6 means about 16% to the upside target against about 9% to the downside, and the breakeven odds drop to the high thirties. A lower price improves the skew. If the miss is a percentage gap like July's rather than a level, that benefit shrinks, so don't lean on it too hard.

Here's how I'd tighten the plan, in two layers. The first is survival, and it's driven by the calendar, not the price. Take Conservative's formula: divide the loss you can tolerate from a gap by the larger of 14% and roughly twice the implied move once you have it. Twice the implied move is my rule of thumb, not something from the data. That's a ceiling on what you carry into the print, whatever the price. The second layer is discretionary and price-driven. Within the ceiling, trim toward half of a standard allocation into strength, in two pieces. Sell roughly a quarter of the position now through 56.8, and the next piece into the 50 SMA area around 57.2 to 57.5. If the stock fades toward 54 first, don't dump the discretionary part, but do get under the ceiling by the close two sessions before the print. If the ceiling is above half, you stop at half. If it's below, the ceiling wins.

On information, the Q2 results should have been public for months. That's a gap in our data feed, not in the market. Read the release and the 10-Q, since they likely explain the Q1 margin collapse and probably the July drop, which I'm inferring was the print. Pull the date from the earnings advisory that's already out, and the implied move from the options chain. I'd make the first trim before any of that, because it holds up under every answer. Then let those three inputs decide whether you go below half.

For the exit, use a plain close below 52.96, but call it what it is, a trend-failure line and not gap protection. If the print gaps through it overnight, read the release before dumping the rest at the open.

If you're flat, stay flat into the print, as you both say. Afterward, I wouldn't make the 58.47 close the only way back in. That level may sit well above where the print leaves the stock. A clear post-print read that margins are stabilizing is a reasonable trigger too, and I'd scale in either way.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: You two have given back most of your weaker points, so what's left is a smaller argument than the one you started with. Viessmann, cash, the current liabilities jump, the z-scores, the negative-skew label and the heavy-volume filter are all conceded. What remains is a broken trend, an event days away, and three missing documents. That's a good reason to trim, but it isn't a bearish thesis, and I think you're both still treating it as one.

Aggressive, you said nobody is recommending zero, so you'll carry half. That argues from where the two ends of this table sit, not from evidence. Half is right only if it fits the holder's loss budget, and you've already agreed to that formula. I'd also drop the idea that July is the best evidence the stock reprices 14% on earnings. The closes went from 69.33 to 63.16, down 8.9%, then to 59.92, down another 5.1%. We're all guessing it was the print. If it was, the overnight gap was about nine percent, and the rest came the next day, when a holder could act. Fourteen is a good stress number, but it isn't the precedent.

Your second tranche also has a mechanical problem. By my arithmetic the 50 SMA is falling about a dime a day, because mid-August closes of 61 to 63 are rolling out of the window. In a few sessions it sits near 56.8, inside your first zone, while your limit waits at 57.2 to 57.5 for a price that may never come. Put the second tranche on a calendar with a deadline.

If this is risk management and not a bear call, re-entry shouldn't depend only on upside confirmation. A miss that gaps to 49 with a release showing margins at a trough could be the best entry in this whole thread.

Conservative, your best new point was that Q1's margin collapse was public before the June peak and the stock rose more than 20% anyway. I'd push it further. We've both been leaning on GAAP operating income, which the market has already looked at, probably alongside adjusted figures and guidance we can't see. So the fundamental case is weaker than the chart case, and the Q2 read is the keystone.

I'd push back on your formula point. You're right that the lookup can only shrink the ceiling. But with a denominator of "the larger of 14% and the implied move," the implied move has to exceed 14% to change anything. For a large-cap industrial that would be unusual, though that's my general knowledge, not our data, and this year's volatility could stretch it. So the lookup is nearly ceremonial under that rule, and defaulting to a quarter until you've done it penalizes skipping a step that probably wouldn't change the answer. That's why I'd scale the denominator to roughly twice the implied move, which makes it a live input.

A quarter is also no less arbitrary than half. Your own example, a half-percent loss budget against a 14% gap, gives a 3.5% maximum weight. Half a standard allocation fits under that unless the standard allocation is above about 7% of the book. So a quarter is right for the concentrated holder, half is right for the diversified one, and the formula tells you which.

On price and probability, I agree it's plausible that a fade through the 10 EMA and the Bollinger middle makes a miss somewhat more likely. But nothing in our data shows a drift to the lower band of a five-week range says anything about the print. Treat it as a reason not to be clever, not as a forecast. Your point that 52.96 and 54 are under two percent apart is fair, and it's why I wouldn't make "don't sell weakness" a creed. If the ceiling says you're over, sell at 54. If you're at or under it, the stop is the stop.

On the extra quarter, the plan's own inputs make it worth somewhere between minus half a point and plus a quarter point of the original position, depending on whose numbers you use. That's smaller than the cost of dithering or sloppy execution.

On timing, the three lookups are an evening's work. If the print lands where Carrier's usually do, in late October, two sessions before could be as soon as the end of this week. I don't have the date, so do the lookups tonight, not "before the second decision."

Here's where I'd land. Sell the first quarter now, since today's 55.83 to 56.62 range already covers it. Compute your ceiling as your tolerable gap loss divided by the larger of 14% and about twice the implied move. Carry into the print the lesser of half a standard allocation and that ceiling. Work the second tranche with a limit around 56.7 to 57.0 for a couple of sessions. If it hasn't filled by the close two sessions before the print, sell at market down to your target. Use a plain close below 52.96 as the trend-failure line, and if the print gaps through it, read the release before dumping the rest. Re-enter on information, meaning a close above 58.47 or a Q2 or Q3 read showing margins stabilizing, and scale in. That applies after a gap down too. If you're flat, stay flat into the print. A put spread below 53 is a fair way to carry more, but only if the options chain prices it sensibly. I have no options data.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: We've narrowed this a lot, so I'll go through where each of you still overreaches and then say where I land.

Conservative, your fourth point was the best thing said in the last round. After all the concessions, what's left is a broken trend and an event we can't price, and that's a sizing argument. I'd push it one step further. Three SuperTrend tiers, price under both averages and the death cross aren't separate pieces of evidence. They're the same fact, a 29% fall, measured five ways. The independent bear case is the trend, the direction of target revisions (which Aggressive himself says lag price), and an unread, unpriced print. That justifies a trim, not a deep one.

That's why your quarter default worries me. Aggressive says sell the first quarter now, and you say carry a quarter if you haven't computed. Those are very different actions. One keeps three quarters of the position, and the other sells three quarters of it on a setup you've both said has an edge worth a fraction of a point. The computation you want is also trivial. It's what you'd carry times 14%, compared with what you'd accept losing on one name in one night. On your own half-percent illustration, half of a standard position only breaks the budget if the standard is above roughly 7% of the book. A holder with a 2 or 3 percent weight doesn't need a default, because half already fits. The ones who need a quarter are the concentrated holders, and they know who they are. So I'd write the fallback as a test, not a number. If your pre-print position times 14% costs more than you'd tolerate, cut until it doesn't.

On buying a gap, your objection that it means buying after support has failed is circular, because every gap-down entry is that by construction. If the rule is absolute, you never buy the scenario with the best skew. I agree with you on two things. Don't buy on day one off a single release, and bound the pause on a gap through 52.96 so you decide by that day's close. But a small starter on day two or three, after the call and some price action, seems reasonable. Fund it from the cash the trim raised.

Aggressive, you've conceded a lot, but a few things are still loose. The bold part of your plan is buying 48 to 50 on a release showing margins have troughed. You've also agreed that Q1 was public before the peak and that nobody here has read Q2, so there's no margin read to be bold about yet. Conservative is right that one release shows deterioration more easily than a trough. Define "trough" before you need it, such as sequential margins stabilizing and guidance holding, not just "less bad than feared." You're also still leaning on "every sell-side action was a cut" after telling us targets lag price. And "nobody is recommending zero" is an argument from where people sit at this table, not from evidence. Half is right only if it fits the budget.

Both of you treat the missing Q2 data as if it only points one way. It doesn't. The July drop priced in whatever management said, and Q3 will be judged against that. The October target cuts also reset the bar. Without the release, the print is closer to a coin flip with fat tails than a bear case.

So for anyone holding CARR, I'd do this:

Sell the first quarter of your position now. Today's 55.83 to 56.62 range covers it, and the session is partial, so don't hold out for 56.8.
Tonight, do the lookups. Read the Q2 release and the 10-Q, and find the earnings date. If you can't confirm it, assume the earliest plausible one and work back. Carrier has historically reported in late October, and the FOMC meets October 28 to 29, so two sessions before could come soon. Pull the implied move if you have options access, since I have none.
Set the ceiling. Carry into the print the lesser of half a standard position and the size where a 14% gap, or about twice the implied move if that's larger, stays inside your one-night loss budget. If the release shows margins still sliding or guidance cut, sit below the ceiling, not at it.
Work the second tranche on a calendar. Use a limit around 56.7 to 57.0 for a couple of sessions. Anything above your ceiling gets sold at market by the close two sessions before the print. If price fades to 54 and you're over the ceiling, sell there. If you're under it, the stop is the stop. Treat the falling 50 SMA meeting price as arithmetic, not news.
Exit the rest on a plain close below 52.96. It's a trend-failure line, not gap protection. If the print gaps through it, read the release and decide by that day's close.
Consider a put spread below 53 only if the chain prices it sensibly. It's the one tool that addresses overnight gap risk.
If you're flat, stay flat into the print.
Re-enter in stages, on information. Start with a daily close above 58.47 or a post-print read showing margins stabilizing. After a gap down, a small starter on day two or three, then add on confirmation.

That keeps the first trim, which holds up under every answer, and lets the three lookups decide how much further to go. It also keeps cash ready for a gap down without pretending we know what the release says.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Conservative, you're right on the sign, and since I wrote the loose version Aggressive inherited, let me fix it. On the plan's own payoffs, plus ten and minus fourteen, a coin flip is worth about minus two percent per unit held. So selling the second quarter earns about half a point. On the friendlier inputs I offered, a clean print near 64 or 65 and a miss nearer 10, holding comes out a quarter to half a point ahead. Change only one input and it's roughly zero. So the edge on that quarter sits within half a point either side of nothing, and nobody here can narrow it.

That cuts against both of you. Aggressive, the residual isn't justified by edge. It's justified by optionality, meaning the squeeze if a clean print gaps up and the cash to buy a gap down, plus the loss budget. Conservative, selling that quarter isn't justified by edge either. The tail argument wins only if the holder's budget says it does. That's why neither half nor a quarter should be the headline. The budget should be.

On the second tranche, your fill problem is real, and I'll own that I wrote it two ways. One paragraph said sell to the target by two sessions before the print, and my list said sell to the ceiling. Those are different plans. Here's how I'd settle it. The ceiling is hard and on the calendar. The half target gets a checkpoint on the same date. If you're above half at that close, you sell to half or you write down why not. The only acceptable reasons come from tonight's reading, such as a Q2 release showing Q1 was a one-time hit, or a small implied move. That isn't Aggressive's "price decides" and it isn't an unconditional rule. The exception also runs the other way. If the release shows margins still sliding, the target sits below half.

On the Q3 2025 comp, I don't think either of you has the better argument, and I'd drop it from both sides. Aggressive calls 9.7% a soft bar. Conservative says the run rate is 4.8%. But our own table has two years pointing opposite ways on seasonality. Q1 2024 was 7.1% against 12.8% in Q3, while 2025 ran 12.1% against 9.7%. Q1 2024 was also the Viessmann closing quarter, which is context, not tool output, so that year is noisy. And calling 4.8% a run rate sits oddly next to a snapshot TTM operating margin of 13.1%, which the report itself says may reflect a different definition. Only the Q2 release can tell us what Q3 should look like.

Conservative is right to tighten the trough definition, because a year-over-year shortfall can narrow just because the comparison quarter is weak. Write it in levels and sequence before the print. Operating margin should be above Q1's 4.8% on GAAP and adjusted, Q1 should be explained in a way that isolates the one-time items, and guidance should be at or above the last stated. Anything short of that is "less bad than feared," and it doesn't count.

On re-entry, you're right that the buy needs its own cap, but not the same cap. The 14% denominator exists because of the event. After the print, the event is behind you, so size the starter to the distance to the new stop. Reusing the pre-print number would keep you smaller than the risk warrants. I'm happy with nothing on day one and a starter on day two or three, after the call and some price action.

On the quarter fallback, I'll accept it, because the sum needs no outside data. It takes only your one-night loss budget and the 14% floor, so nobody has an excuse not to do it. The default should almost never bind, and it applies only to someone who skipped a five-minute calculation.

You also caught a real ambiguity. "A quarter of a standard allocation" and "a quarter of your position" aren't the same thing, and we don't know anyone's holdings. So I'd put everything in weights against a standard allocation of one. The cap is your tolerable one-night loss divided by the larger of 14% and about twice the implied move. The target is the lesser of half and that cap. If you're already at or below the target, there's nothing to sell.

On the put spread, Conservative is right that it only covers between the strikes. A 53/48 spread handles the plan's stress case but not a gap to 46. It's a way to carry more than the cap, not a substitute for the cap, and only if the chain prices it sensibly. I have no options data.

One more thing for both of you. We've spent several rounds on a quarter-point disagreement while the print may be days away. Neither extreme is free. Selling too much costs a bounded amount if the print is clean, and holding too much costs a lot if it isn't. But the bigger risks are sloppy execution and missing the deadline, so do the lookups tonight. That means the Q2 release and 10-Q, the earnings date, and the implied move. If Comfort Systems reports first, treat it as a read-through on HVAC demand.

So here's where I land. Sell the first quarter of what you hold now, but never below your target weight. Today's range covers it and the bar is partial, so don't hold out for 56.8. Work the next piece with a limit around 56.7 to 57.0 for a couple of sessions. By the close two sessions before the print, you're at or under the cap, and at the target unless tonight's reading earned an exception. Exit the rest on a plain close below 52.96. It's a trend-failure line, not gap protection. If the print gaps through it, read the release before the open and decide by that day's close. Re-enter in stages on information, either a close above 58.47 or a read that meets the written trough definition. If you're flat, stay flat into the print. "Sell" here means reduce. It isn't a short.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: We're now trading quarter-points, so I'll say what I'm taking from each of you and where each of you still has a loose end.

Conservative, you're right on four things. The cap has to be converted into standard-allocation terms before anyone takes the lesser of it and half, because a percent of the book and a fraction of a standard allocation aren't the same unit. Anything above the cap should go as soon as the sum is done, not wait on a resting limit, since nobody is paid to hold risk they've said they can't afford. A small implied move can't justify carrying more, because the 14% floor means anything under roughly 7% changes nothing, and counting it again is double dipping. And optionality can't separate a quarter from a half, since the residual and the cash both exist at any size between zero and full.

Here is the sum in concrete terms. Say your tolerable one-night loss on this name is half a percent of the book. Divided by 14%, the cap is about 3.5% of the book. If a standard allocation is 5% of the book, the cap is 0.7 of standard, so half binds. At 10% the cap is 0.35, so you sell more than half. At 2% you're nowhere near it.

Conservative, I'd still push back on two things. First, your starter gate. You cap the post-gap buy at the quarter fallback until the stock closes back above 52.96. If the print gaps to 48-50, that's a 6 to 10 percent climb before you can size up. Aggressive's version had two doors, a reclaim of 52.96 or a read that meets the written definition. Yours drops the second, which makes the trough test decorative on the buy side. Keep both doors, but keep your cap and your post-print ATR sizing on the first buy, because that's the one made on the worst tape.

Second, the July veto. You'd refuse to let the Q2 release justify more than half because the market may have sold it. You flagged that as an inference, and you also pointed out that the stock was back at 61 to 63 by mid-August, so the tape's verdict on that document is murky. Test the release on what it says, not on what the stock did two months ago. The test should also run the other way. If the release shows margins still sliding or guidance cut, the target drops below half whatever the implied move is.

Aggressive, you're still mixing units. You say sell the first quarter of what you hold, then say the plan is in weights. A quarter of your holding means something different at 2x standard than at 0.6x. Say it as at least a quarter of a standard allocation now, or the whole excess if that's smaller. Your limit at 56.7 to 57.0 for a couple of sessions may also be the entire runway. The date is unconfirmed and today is Wednesday. I believe Carrier usually reports before the open, though that's memory, not our data. If so, the last close before the print is the real deadline, and the checkpoint two sessions out leaves one session of slack. Treat the limit as a courtesy, not a plan. And if you're over your cap and the stock fades to 54, sell there. The old "don't sell weakness" line only applies to someone already inside the cap.

Neither of you has caught a flaw in the trough test you wrote. In our own table, Q2 margin beat Q1 in both years, by about five points in 2024 and 2.7 in 2025. So a Q2 margin "above Q1's 4.8%" passes on seasonality alone. The year-over-year version has the opposite flaw, since it can narrow on a weak comp. Using 2025's pattern, a seasonal step-up of 2.7 points puts Q2 at about 7.5%, and a year-over-year shortfall narrower than Q1's 7.3 points against Q2 2025's 14.8% puts it at the same 7.5%. So write the threshold in levels before you open the release, and treat roughly 7.5% on GAAP as a floor that merely matches last year's seasonal step, not as proof. That's my arithmetic from two years of data, and the 2024 step was distorted by the Viessmann closing, which is context, not tool output. For adjusted figures I have no data, so compare against the company's own prior-year adjusted margin. Pass that, with Q1's items itemized and guidance at or above what was last given, and carrying above half up to the cap is defensible. Miss any of it and half is the ceiling.

Here's where I land. Tonight, read the Q2 release and 10-Q and find the earnings date, assuming the earliest plausible one if you can't confirm it. Pull the implied move if you have an options chain, which I don't. Write your threshold before opening the release, then do the cap sum. Sell at least a quarter of a standard allocation now. Today's 55.83 to 56.62 range already covers the zone, and the session is partial. Sell everything above your cap at the first opportunity after the sum. By the close two sessions before the print, hold the lesser of half and the cap, with above half allowed only if the Q2 release passes the written test. Anyone who skips the sum carries a quarter.

Exit the remainder on a plain close below 52.96. That's a trend-failure line, not gap protection. If the print gaps through it, read the release before the open and decide by that day's close. After a gap, buy nothing on day one. Start with a small starter on day two or three, capped at a quarter of a standard allocation and sized from post-print ATR. Larger adds need either a close back above 52.96 or a release that passes the test. A put spread below 53 is a way to carry more than the cap, not a substitute for it, and only if the chain prices it sensibly. If you're flat, stay flat into the print and place no pre-print buys. Sell here means reduce, not short.

That's the middle path. The first trim holds up under every answer, the budget decides the rest, and a test written before the information arrives decides whether anyone earns the right to carry more.

FINAL TRANSACTION PROPOSAL: SELL

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary: Underweight CARR means reduce, not exit and not short. Holders should sell at least a quarter of a standard allocation now into the 55.8–56.8 area, since today's partial session already trades in the zone. They should be at or below a target weight by the close two sessions before the unconfirmed Q3 print. That target is the lesser of half a standard allocation and a loss-budget cap: your tolerable one-night loss on the name divided by the larger of 14% and about twice the options-implied move, converted into standard-allocation units. Anyone who skips that calculation should carry a quarter. Exit the residual on a plain daily close below 52.96, which marks trend failure but does not protect against a gap. Flat accounts should stay flat with no pre-print bids. Rebuild only after a daily close above 58.47 combined with a margin read that passes the written test below, or after a clean Q3 print. The horizon runs through the print and the post-print revision cycle, roughly 3–6 weeks.

Investment Thesis: The debate never split on direction. All four voices, the Research Manager, the trader and all three risk analysts, landed on reduce. What they argued over was size, and that argument mostly resolved, so this is a sizing call made with conviction rather than a Hold.

What survived scrutiny: (1) The trend is broken. The 50 SMA crossed below the 200 SMA on 09-24, SuperTrend is down on the daily (58.47), weekly (66.98) and monthly (75.97) charts, and price sits below the 50 SMA (57.23) and the 200 SMA (61.51). As Neutral noted, this is one fact, a 29% fall from 75.73, measured five ways, and the conservative side accepted that. (2) A binary event is days away and cannot be priced. The Q2 2026 release and 10-Q, the confirmed earnings date and the implied move are all missing from our evidence. FOMC on Oct 28–29 may overlap. (3) A gap can only be controlled by position size. A close-based stop cannot fire on an overnight gap. July shows the stock can lose 13.6% in two sessions (69.33 to 63.16 to 59.92 on about 16M shares a day).

On the plan's own payoffs, a clean print stalls at 61–64, where the 200 SMA, Goldman's $61 and Bernstein's $64 sit (+10%), and a miss gaps to 48–50 (-14%). A coin flip on those numbers is worth about -2% per unit held, and breakeven needs about 57% confidence in a clean print. Under friendlier inputs the extra quarter of position sits within roughly half a point of zero expected value, while its added gap exposure (about 3.5 points of the original position) is fixed. When the edge cannot be told apart from zero and the tail is a gap, the tail decides, scaled to each holder's loss budget. That is why the target is the lesser of half and the cap. Half is a ceiling, not a recommendation.

Price location supports trimming now. The stock is at the top of a five-week 53.88–56.37 close range, near the upper Bollinger Band (56.54), with a daily z-score of +1.53. The bounce volume (about 4.9M on 10-20) is average. OBV's 24M rebound mostly refills the early-October distribution hole.

Fundamentals are bad but weaker as a pillar than first argued. Q1 2026 operating margin was 4.8% vs 12.1% a year earlier, FCF was -$15M vs +$420M, the dividend absorbs about 90% of TTM FCF, cash is $1.37B and the current ratio is about 1.05. Conservative correctly noted that Q1 was public before the June peak and the stock still rallied, so the Q2 release is the keystone document.

Why not Sell: - The residual keeps the squeeze if a clean print gaps up. Gaps skip prices, so re-entry would mean paying through them. - About 75% of the rally has been given back. - The CEO bought at $52.62. - The Q3 comp and seasonality point both ways, so the print is closer to a fat-tailed coin flip than a bear case.

Several arguments were conceded and dropped: Viessmann's $62.01 block as resistance, the cash drain, the jump in current liabilities, the z-score as 'room to fall', and the direction of target cuts as a forecast (targets lag price).

Execution rules: - Sell any size above the cap at the first opportunity once the sum is done; do not wait on a resting limit. - Work the remainder with a limit around 56.7–57.0, but enforce the target on the calendar by the close two sessions before the print. Assume the earliest plausible late-October date if it is unconfirmed. - If you are over the cap and the stock fades to 54, sell there anyway.

Written margin test, set before reading the Q2 release: - GAAP operating margin of at least about 7.5%. A level 'above 4.8%' passes on seasonality alone, and Neutral's arithmetic shows 7.5% only matches 2025's seasonal step. - Q1's one-time items itemized. - Guidance at or above the last stated level. Carrying above half, up to the cap, is allowed only if all three hold. A small implied move does not count twice.

Upgrade to Hold or Overweight: the test passes, plus a daily close above 58.47 or a clean Q3 (margin clearly above 9.7% with guidance supporting about $3.31). Add in tranches through the 61–64 supply zone.

Downgrade to exit: a plain close below 52.96, Q3 operating margin below 9.7%, or a guidance cut. If the print gaps through 52.96, read the release before the open and decide by that day's close.

After a gap down: buy nothing on day one. A starter on day two or three is allowed, capped at a quarter of a standard allocation and sized from post-print ATR. Larger adds need a close back above 52.96 or a release that passes the test.

Price target $55.75, probability-weighted: 0.5 × 62.5 (midpoint of the 61–64 clean-print supply zone) + 0.5 × 49 (midpoint of the 48–50 miss zone) = 55.75, about 0.9% below the 56.27 close. This reflects the debate's 'coin flip with fat tails' conclusion. Cross-checks: - Valuation: 17x × $3.31 forward EPS = $56.27, so the current price already assumes full delivery of a 2.4x jump from $1.38 TTM GAAP EPS. A 10% trim to forward EPS at the same multiple implies about $50.6. - Technical: the target sits near the 10 EMA (55.50) and Bollinger middle (55.41), with the 53.88 swing low as the bearish-resumption reference.

Data caveats: the 10-21 bar is a partial session (about 1.74M shares), so the 56.27 close may still change. The financial statements end at Q1 2026. It is unknown whether $3.31 refers to FY26, NTM or FY27. There is no options, consensus-revision or macro rate data. These gaps lower confidence in the target, not in the decision to reduce.

Current Price: 56.27

Price Target: 55.75

Confidence: Medium

Time Horizon: 3-6 weeks